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LITERARY OVERVIEW 
Definitions 
Hungary is rich in thermal mineral waters due to its favourable hydrogeological 
endowments. Moving towards the centre of the Earth temperature rises. Geothermic gradient 
gives the distance in meters needed to get a temperature increase of 1°C. The temperature 
increase varies between 5-70°C per kilometer. In Hungary the average value of geothermal 
gradient is between 5-7oC/100 m, which is about 1.5 times higher than the world average. The 
reason for this is that the earth crust in the Pannon basin is thinner than the world average, and 
the basin is filled with sediments of good insulation potential. Regarding their chemical 
composition, mineral waters show great variation. The composition is determined primarily 
by the geological environment. Mineral waters can be extracted from the subterranean waters 
by natural processes, by springs, or by artificially drilled wells. Due to the geological 
structure and the geographical terrains in Hungary relatively few natural springs break up to 
the surface. In Hungary, there are two major hot spring reservoirs. One is under the great 
Plain, Small Plain and Drava riverside areas, containing the sodium-hydrogen-carbonate 
remains of the Pannon Sea, and in the deeper layers, sodium-chloride. The other is under the 
Transdanubia Hills containing calcium-magnesium-hydrogen-carbonated mineral water. The 
hot spring reservoirs are accessed by drilled wells to extract mineral water [1,2]. 
Mineral waters may be classified by several aspects. The most accepted way of 
classification is grouping by chemical composition. Considering their composition, the 
mineral waters are classified as: salty (rich in calcium-chloride, magnesium-chloride), 
carbonated (sour waters), alkaline or calcined lime (sodium-hydrogen-carbonated, 
magnesium- hydrogen-carbonated), rich in iron, in iodine, in bromide, in sulfate, in sulfide, 
and radioactive waters. The role and impact mechanism of the organic content in mineral 
waters is not fully understood. The survey of organic content in mineral waters has been 
started [3]. 
In Hungary, the definition of natural healing factor as well as the accreditation and use 
of mineral waters, medical waters and thermal mud are regulated by national law. The water 
can be recognized as mineral water if it contains dissolved solid minerals of at least 1000 mg 
per liter, or a specified quantity of minerals of specific impact, and it should not contain any 
materials harmful to human health, and the dissolved mineral content and chemical character 
  
10 
should be stable. Medicinal water is a natural mineral water with healing properties proven by 
medical research [3]. 
In countries having no thermal water the medical use of tap water is widespread, and it 
is called hydrotherapy [4]. 
Balneotherapy a medical specialty using the beneficial effects of naturally found 
mineral waters, gases, and peloids. The most important modalities of use are bathing, drinking 
and inhalation. Bathing is immersion of the body or of body parts into water, peloid or gas. 
Drinking is a treatment method using ingestion of mineral waters. Inhalation is the application 
of aerosols from mineral waters and/or natural gases via the respiratory tract [5,6]. 
The term balneotherapy comes from the Latin balneum (bath). It is called 
crenotherapy in France and Southern Europe. The term „spa therapy” is generally used in the 
English speaking world. The Vallonic word „espa” means „spring”, and this word is the 
origin of the name of the Belgian town Spa, where a healing thermal spring was discovered in 
the 14th century [7]. Spa therapy is complex patients receive treatment not only with thermal 
mineral water but also other modalities, such as massage, electrotherapy, and exercise [8]. 
Balneology is often not recognised as independent medical specialty at a global 
international level, because of the lack of scientific evidence, and the fact that balneotherapy 
is not available in all countries. A paper published in 2010 suggested the introduction of a 
new terminology, and medical field. This medical area can be defined as “medicine in health 
resorts” or “health resort medicine”. “Health resort medicine includes all medical activities 
originated and derived in health resorts based on scientific evidence aiming at health 
promotion, prevention, therapy, and rehabilitation [5]”. 
In Hungary, the various balneotherapeutic options are widely available. In general, one 
therapeutic cycle consists of 15 to 20 sessions lasting at least 20 to 40 minutes each for a 
beneficial therapeutic effect [9]. Balneotherapy is usually part of a complex physiotherapeutic 
treatment. Balneotherapeutic procedures are mainly performed in musculoskeletal diseases 
[10] but their use have also been reported in various other indications such as in the treatment 
or rehabilitation of dermatological (psoriasis, atopic dermatitis) [11,12,13], gynaecological 
[14], chronic venous insufficiency [15,16], chronic occlusive arterial disease [17], or 
psychiatric conditions (generalized anxiety disorder) [18] as well as in the rehabilitation of 
oncology patients [19]. 
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Lake Hévíz 
Lake Hévíz deserves a special place within balneology/balneotherapy. The history of 
the lake goes back to the beginnings of the geological Middle Ages. Hévíz is the very last 
spring on the South-west of the karst waters stretching along the dolomites and karsts of the 
upper triassis of the Transdanubian mountains. We have several evidences to prove that the 
thermal water didn’t spring on the recent water level but much higher than that. It started 
about 20-22 thousand years ago at the same place as it is today probably at the same time as 
Lake Balaton was forming. The rising water first was flowing into Lake Balaton. As an effect 
of climate changing the water level of Balaton was lowering. In the former basin of the lake 
peat was created from the plants living there before. As a result of this procedure the bottom 
of the lake, as well as the swamp around it consists of thick peat. Lake Hévíz is a biologically 
active, natural thermal lake located in West Hungary. It is Europe’s largest warm water lake; 
only one natural formation similar to it exists in Rotorua, New Zealand. The spring of the 
lake, which has a water surface area of 45.000 m2, is rich in minerals and is located 38 m deep 
at the bottom of a vertical sandstone wall. The spring cave of the lake is divided into two 
halves by a mud layer. Several springs flow into the cave: one with cold karst water on the 
east side and one with thermal water on the west side. The spring feeding the lake keeps the 
water of the lake in a constant motion: the emerging water drifts towards the shores of the 
lake with slow circulation. The discharge of the lake is 410 L/sec and with this the total water 
volume of the lake is replaced in about every three and a half days. The water of the lake is 
lead to river Zala by two canals and from there to Lake Balaton. During summer, water 
temperature reaches 37-38°C and it does not drop below 22-23°C even in winter. Resulting 
from the eventful earth history and geological characteristics, the lake forms a 
hydrogeological unit together with the surrounding moorland and marshland, which has a 
unique, special fauna characteristic for a hot spring [20]. The bed of the lake is covered with a 
6 to 8 m thick mud layer. The microorganisms and their metabolites found in the water and in 
the mud contribute to the biological effects of the lake [21]. Károly Moll was the first in the 
world who applied the underwater traction in the form of weight-bath [22]. The therapy was 
developed at Lake Hévíz. Based on the lake and its special climate, Hévíz became a health 
resort with preventive, curative, and rehabilitative functions in the last centuries with adequate 
health care system and infrastructure. 
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Assumed mechanism of action of hydro- and balneotherapy 
The effects of balneotherapy are partly attributable to the aquatic environment and its 
basic physical characteristics as well as the effects of substances dissolved in the water 
[23,24]. Physiological changes evoked by the physical characteristics of water are well 
known. However, the role of dissolved minerals and organic substances in the mechanism of 
action of balneotherapy is not yet completely understood [25]. We call immersion when the 
body is dipped into water up to substernal height in a vertical position. The efficacy of 
hydrotherapy is explained by the water environment, the basic physical attributes of water i.e. 
its density, specific weight, hydrostatic pressure, buoyant force, viscosity and temperature 
[26]. On immersion, superficial veins are compressed, venous return is enhanced and central 
venous pressure, cardiac volume, stroke volume, and cardiac output are also increased [27]. 
At the same time, peripheral vascular resistance decreases. The redistribution of this higher 
cardiac output leads to an increased skin and muscle perfusion. The extent of cardiac output 
increase depends on age, sex, and water temperature [28]. Due to hydrostatic pressure, the 
circumference of body parts is reduced. On immersion to neck level, thorax is also under 
pressure. Moreover, enhanced thoracic blood return affects breathing as well. Vital capacity is 
reduced, inspiration is more difficult, and ventilation effort is increased. While breathing on 
immersion, primarily the muscles of inspiration exhibit an increased action [29]. Increased 
diuresis with a pronounced natriuresis and a less pronounced kaliuresis are seen. Vasopressine 
levels and plasma renin activity fall while atrial natriuretic peptide levels rise [30,31,32]. The 
initial haemodilution gradually normalizes [33]. 
On immersion, water is displaced by the body, generating upward buoyant force and 
gradually relieving submerging joints [26]. While moving in the water, internal friction is 
developed which depends on the viscosity of the fluid. As a result, certain movements are 
easier while others e.g. walking is more difficult to carry out. [34]. A man of 0.97 kg/m3 
density reaches a static equilibrium, or neutral buoyancy if 97% of his body is submerged into 
water [26]. Kjellgren et al investigated the floating form of the restricted environmental 
stimulation technique on patients suffering from chronic pain in the neck and back area. The 
flotation restricted environmental stimulation technique induced a significant reduction of 
pain intensity, anxiety and depression, significantly shorter latency to fall a sleep at night, and 
a significant decrease of noradrenaline metabolite values in the blood [35].  
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Water is an excellent therapeutic medium due to the combination of its high thermal 
capacity and high thermal conductance [36]. The analgesic effect of warm water is also 
explained by the gate control theory. Skin thermoreceptors and mechanoreceptors stimulated 
by the temperature and the hydrostatic pressure of water activate inhibitory interneurons 
acting on ascending nociceptive neurons, which, in turn, leads to the blockage of pain signal 
conductance [37]. Thermal effect induces changes in the neuroendocrine regulation. Heat as 
stress factor stimulates the secretion of adrenocorticotropic hormone, cortisol, prolactin, and 
growth hormone [38]. The increase of beta-endorphin levels was observed after bathing in 
hyperthermic mineral water or mud treatment. Elevated beta-endorphin level is thought to 
play a role in the development of tolerance to the substantial heat exposure associated with 
bathing. Repetitive elevation of beta-endorphin levels may contribute also to the mitigation of 
joint and muscle pain [39]. Water temperature has a delicate impact on the peripheral nervous 
system and the balance of sympathetic and parasympathetic effects. Becker et al examined 
biophysiologic effects of different temperatures water immersion to the autonomic nervous 
system. When compared with cool and neutral immersion, warm water immersion still 
produced a rise in sympathetic power with a small drop in sympathovagal balance from 
baseline. A rise in sympathovagal balance is associated with stress reduction, positive 
emotions. Such a physiologic change causes a decrease in cardiac irritability, a reduction in 
blood pressure, and a decrease in anxiety [40]. Thermal stimulation increases the extensibility 
of collagen-rich tissues, such as tendons, fasciae and articular capsules, which may improve 
the range of motion of joints [41]. By reducing muscle tone [35] and joint circumference [42] 
it contributes to the relief of musculoskeletal pain. 
There is some evidence for the skin absorption of inorganic elements and organic 
substances from mineral waters. In a trial involved patients with psoriatic arthritis the authors 
detected a relevant increase in serum concentrations of bromine, rubidium, calcium, and zinc 
after bathing in the Dead Sea [43]. Hildebrandt and Gutenbrunner described relevant 
penetrations of sulphide through the skin by sulphide baths [44]. Nagy et al detected, that 
radon was capable of entering the human body through the skin during the bath therapy, and 
then was leaving it in a measurable quantity with the air exhaled. They demonstrated that the 
radon bath treatment may have an influence on endocrine organs. [45]. Experimental studies 
in animal models corroborate the evidence of beneficial effects of sulphurous balneotherapy 
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on inflammatory diseases. Pozsgai et al have recently demonstrated an anti-inflammatory 
effect of sulphurous mineral water in dextran sulfate sodium evoked colitis in mice. Oral 
administration of Harkány thermal spring water significantly attenuated general signs of 
colitis [46]. In a study published in 2013 the effect of sulphurous medicinal water in a murine 
dermatitis model and on psoriatic patients was observed. The results provided evidence that 
somatostatin released by hydrogen sulfide plays role in the mechanism of action of 
sulphurous medicinal water [47]. The thermal stress has an immunosuppressive effect. In an 
in vitro study Markovic et al perceived that hyperthermia were able to suppress a series of 
pro-inflammatory genes (IL-1α, IL-1β, TNF-α, IL-8, monocyte chemoattractant peptide-1 and 
cyclooxygenase-2) expression [48]. In ankylosing spondylitis patients, mild whole body 
hyperthermia caused a significant reduction of systemic levels of TNF-α, IL-1β, and IL-6 [49]. 
In addition to heat effect, immunosuppression might be mediated by chemical elements as 
well. In an in vivo study, a significant increase in TGF-β1 was found in ankylosing 
spondylitis patients after spa (radon) therapy [50]. 
The decrease of pro-inflammatory prostaglandin E2 levels was seen after 
balneotherapy in patients suffering from fibromyalgia [51]. Balneotherapy induced a change 
in the concentration of pro-inflammatory markers playing an important role in osteoarthritis 
development as well as in the activity of cartilage-degrading proteases. In vitro studies 
demonstrated that sulfurous mineral water decreases IL-1β induced activation of fibroblast-
like synoviocytes from patients with osteoarthritis [52]. Belometti et al found significant 
decrease of matrix metalloproteinase-3 levels after mud therapy [53]. Adipocytokines, 
including adiponectin, resistin may play an important role in the pathophysiology of 
osteoarthritis. Fioravanti et al measured the circulating levels of adiponectin, resistin after 
mud and balneotherapy in patients with knee osteoarthritis. A significant reduction of serum 
resistin and adiponectin was shown in knee patients after mud and balneotherapy [54]. 
The sulphur baths have effects on biochemical parameters. Ekmekcioglu et al 
demonstrated that sulphur baths can reduce the antioxidative defense system in the blood and 
moderately improve the lipid status [55]. Leibetseder et al showed that sulphur baths 
positively influence plasma homocysteine level [56]. Bender et al reported that balneotherapy 
has an influence on the antioxidant system, reducing the activity of catalase, superoxide-
dismutase, malondialdehyde, and glutathione-peroxidase [57]. 
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The definition, epidemiology, clinical presentation and recommended treatment of 
chronic low back pain 
Low back pain (LBP) is a major public health concern in many countries. LBP is the 
fifth most common reason for a patient to visit a physician’s office in the United States of 
America [58]. The lifetime prevalence of LBP is up to 84%. Peak prevalence occurs between 
ages 35 and 55 years [59]. LBP may prevent patients from returning to work and impair 
individuals to engage in activities required for daily living. 
LBP is a multifactorial disorder with many possible etiologies, risk factors, and co-
morbidities. LBP designates pain or muscular tension between the margins of costae and the 
inferior gluteal folds that may be present with or without pain radiating to the leg. It is 
classified as specific LBP if it is caused by non mechanical spinal disorders/organic diseases 
such as cauda equina syndrome, spinal fracture, cancer, infection, spondyloarthritis, 
gastrointestinal or genitourinary diseases known as „red flags”. Undertake diagnostic triage 
consisting of appropriate history taking and physical examination at the first assessment to 
exclude serious spinal pathology and nerve root pain. If serious spinal pathology and nerve 
root pain are excluded, manage the low back pain as non-specific [59]. The majority of 
patients seeking care for LBP do not have a specific pathology or disease responsible for their 
symptoms, 85% to 95% of patients with low back pain do not have red flags [58]. 
Pathophysiologically, LBP may be caused by lumbar intervertebral discs, facet joints, 
sacroiliac joints, ligaments, fascia, muscles or nerve root dura which are capable of 
transmitting pain in the lumbar spine. Several concerns are related to the probability of a 
patient with chronic low back pain returning to work. Yellow flags were designed to identify 
patients with psychiatric disorders, emotional problems, or socioeconomic issues who could 
develop chronic pain and long-term disability. The assessment of prognostic factors in 
patients with chronic low back pain is recommended [59]. Back pain is usually defined as 
acute if it lasts less than six weeks; subacute if between six weeks and three months; and 
chronic when it lasts more than three months. Although 60% of people who have LBP recover 
in a few weeks and often with minimal intervention, for the other 40%, recovery is slow and 
the risk of developing long-term symptoms, or chronic LBP, is high. The risk factors for a 
new episode of back pain are: a previous history of back pain, heavy physical work, frequent 
bending, twisting, lifting, pulling and pushing, repetitive work, static postures and vibrations 
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[60,61]. Diagnostic imaging tests are not routinely indicated for non-specific low back pain. 
They serve two purposes: to evaluate patients with red flags or radicular pain, and to plan 
surgical techniques in those for whom surgery is being considered [59]. 
According to the Joint Clinical Practice Guideline from the American College of 
Physicians and the American Pain Society for Diagnosis and Treatment of Low Back Pain: 
clinicians should provide patients with evidence-based information on low back pain with 
regard to their expected course, advise patients to remain active, and provide information 
about effective self-care options. Furthermore clinicians should assess severity of baseline 
pain and functional deficits, potential benefits, risks, and relative lack of long-term efficacy 
and safety data before initiating therapy [62]. 
According to the Physical and Rehabilitation Medicine Section and Board of the 
European Union of Medical Specialists recommendation for the management of chronic LBP 
articles published in 2013, for pharmacological treatment paracetamol, nonsteroidal anti-
inflammatory drugs, tramadol and opioids, tricyclic antidepressants, duloxetin, for non-
pharmacological modalities, education, back schools, exercise, massage, spinal manipulation, 
cognitive-behavioral therapy, multidisciplinary biopsychosocial rehabilitation were 
recommended. Management of LBP is strongly recommended by interdisciplinary 
rehabilitation team [63].  
In an article published in 2011, the implications of evidence based practice guidelines 
recommendations for physical therapy practice for management of low back pain were 
reviewed. Sixteen guidelines were evaluated. The number of guidelines addressing chronic 
LBP (nine out of sixteen) was a little over half of that for acute LBP. The intervention choices 
for non-specific LBP were similar in the majority of the guidelines for acute (education, 
exercises, and spine manipulation), subacute (same as acute plus back school, behavioral 
counseling, or multidisciplinary rehabilitation), and chronic LBP (education and exercise plus 
back school, behavioral counseling, or multidisciplinary rehabilitation). Patients without red 
flags could be safely managed without specialist referral [64]. 
Balneotherapeutic procedures are often used by physicians and preferred by patients 
for the treatment of chronic low back pain. Because of the limited scientific evidence the 
balneotherapy are not included in the treatment guidelines for LBP. 
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The definition, epidemiology, clinical presentation and recommended treatment of 
osteoarthritis 
Osteoarthritis (OA) is thought to be the most prevalent chronic musculoskeletal 
disease. It usually results in pain and deformity, leading to chronic disability [65]. Limited 
movement ability of the joints, significant pain, and decreased muscle strength may develop, 
which may interfere with daily activities and overall quality of life. Worldwide estimates are 
that 9.6% of men and 18.0% of women aged ≥ 60 years have symptomatic OA. OA was 
estimated to be the eighth leading non-fatal burden of disease in the world in 1990, 
accounting for 2.8% of total years of living with disability [66]. The incidence of 
osteoarthritis is rising because of the ageing population and the epidemic of obesity.  
The prevalence of OA depends on the precise definition used. In a paper published in 
2011, OA prevalence was studied in meta-analysis by sex and joint site (only data for knee, 
hip, and hand joints were evaluated) the highest OA prevalence estimates were found in hand 
joints and the hip is the joint with the lowest prevalence. OA of the knee tends to be more 
prevalent in women than in men but no gender differences were found in hip and hand OA. 
Higher OA prevalence was found in older populations. The analysis showed a higher 
prevalence when radiographic definition was used in all age groups and for both genders [67]. 
In the European Project on Osteoarthritis study, prevalence of knee OA was the highest, 
followed by hand OA, and hip OA, for both self-reported and clinical OA. Cross-national 
differences are observed in prevalence rates of both self-reported and clinical OA [68]. 
OA is characterized by focal areas of loss of articular cartilage within synovial joints, 
which are associated with hypertrophy of bone, osteophytes and subchondral bone sclerosis, 
and thickening of the capsule. Pathologic abnormalities are also present in periarticular 
muscle, ligaments, synovium, and in the neurosensory system. OA is a complex active 
degradative and repair process of cartilage and subchondral bone with a synovial 
inflammation. Risk factors of OA are obesity, female sex, ageing, oestrogen deficiency, 
family history, active subarticular bone remodeling, joint laxity, sport or occupational joint 
overload, prior injury with damaged ligaments and menisectomy, misalignment. Clinically, 
the condition is characterized by joint pain, tenderness, limitation of movement, crepitus, 
occasional effusion, and variable degrees of local inflammation. OA is classified into two 
groups according to the etiology of the disease: primary and secondary. In hand osteoarthritis, 
  
18 
the most affected joints are the distal and proximal interphalangeal joints of fingers II to V 
and the carpometacarpal joint of finger I [69]. The extent of functional damage of the hand 
may be similar to that of in rheumatoid arthritis [70]. The American College of Rheumatology 
(ACR) has proposed a set of criteria for OA depending on each joint [71,72].  
Management requires early diagnosis and awareness of the risk factors that can affect 
the prognosis. In recent years a number of international evidence based guidelines developed 
for the management of OA. The guidelines included evidence and recommendations for a 
number of interventions including: pharmacological, non-pharmacological, surgical therapies, 
physical management and lifestyle changes for the management of OA. The therapeutic 
recommendations for OA emphasize the importance of reducing joint pain and stiffness, 
preserving joint mobility, and improving physical disability and quality of life [73,74,75].  
In 2012 the ACR has produced recommendations for the use of non-pharmacologic 
and pharmacologic therapies in OA of the Hand, Hip, and Knee. Both “strong” and 
“conditional” recommendations were made for OA management. Modalities conditionally 
recommended for the management of hand OA include instruction in joint protection 
techniques, provision of assistive devices, use of thermal modalities and trapeziometacarpal 
joint splints, and use of oral and topical nonsteroidal anti-inflammatory drugs (NSAIDs), 
tramadol, and topical capsaicin. Non-pharmacologic modalities strongly recommended for the 
management of knee OA were aerobic, aquatic, and/or resistance exercises as well as weight 
loss for overweight patients. Non-pharmacologic modalities conditionally recommended for 
knee OA included medial wedge insoles for valgus knee OA, subtalar strapped lateral insoles 
for varus knee OA, medially directed patellar taping, manual therapy, walking aids, thermal 
agents, tai chi, self-management programs, and psychosocial interventions. Pharmacologic 
modalities conditionally recommended for management of patients with knee OA included 
acetaminophen, oral and topical NSAIDs, tramadol, and intraarticular corticosteroid 
injections; intraarticular hyaluronate injections, duloxetine, and opioids. Recommendations 
for hip OA were similar to those for the management of knee OA [76]. 
Joint replacement is an effective intervention to alleviate pain and improve quality of 
life for those with advanced OA. However, despite a growing number of joint replacements 
undertaken each year many people are still placed on a waiting list often for a considerable 
time. In order to reduce the burden of OA, safe and effective health services, involving a 
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range of non-surgical treatments options are required. These therapies must be effective with 
respect to intervention and cost as well as meet the affected person’s needs. Due to adverse 
side effects, patients and health care providers may pursue physical management options 
rather than surgery, pharmacology, or injection based therapy. In the systematic review of 
seventeen guidelines for the physical management of OA forty therapeutic interventions were 
identified across the guidelines. Strongly recommended interventions included: exercise 
(combined exercise or unspecified type, aerobic, strengthening, aquatic/hydrotherapy, land 
based, yoga), transcutaneous electrical nerve stimulation, equipment (knee bracing, 
appropriate footwear, wedged insoles), education (pain management program, individual 
education, group education, pre-operative education, collective information), manual therapy 
(manual therapy with supervised exercise, manipulation and stretching), diet and weight loss, 
combinations of diet, physical activity, and social cognitive theory, self-management and 
psychosocial based therapy, balneotherapy (however only two guidelines provided 
recommendations for balneotherapy) [77]. 
In the recently published OARSI (Osteoarthritis Research Society International) 
Guidelines for Non-Surgical Management of Knee Osteoarthritis, balneotherapy was 
considered as an appropriate treatment for specific clinical subphenotypes with multiple joint 
osteoarthritis and comorbidities, based on systematic review and metaanalysis of randomized 
controlled trials [78]. 
 
Evidences supporting the efficacy of balneotherapy in low back pain and osteoarthritis 
Evidence-based practice is the integration of clinical expertise, patient values, and the 
best research evidence into the decision making process for patient care. The best research 
evidence is usually found in clinically relevant research that has been conducted using sound 
methodology. There is an accepted hierarchy with respect to research evidence for the 
efficacy of treatments, the highest level being meta-analysis of randomised controlled trials 
(RCTs) [79]. Assessing the effectiveness of non-pharmacological treatments presents specific 
methodological issues. In non-pharmacological treatments trials, it is often difficult to 
perform sham intervention, and blinding of participants is frequently impossible. Intervention 
with balneotherapy also has the same issues. The success of balneotherapy often depends on 
environmental and other specific factors such as chemical and thermal characteristics, type of 
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bath, nature, and combined intervention [80]. Despite the difficulties of organizing trials in 
the past decades, several clinical studies have evaluated the efficacy of balneotherapy mainly 
in the treatment of musculoskeletal diseases. Unlike for drug trials, the lack of adequate 
funding of balneology research makes it difficult to enroll sufficient numbers of patients in 
such trials. The metaanalysis of completed trials in balneotherapy is challenged by the 
diversity of their methods, therapies, and outcome parameters. 
The number of studies on the effects of thermal water in the treatment of chronic low 
back pain is relatively small. A meta-analysis published in 2006 assessed the evidence for or 
against the effectiveness of spa therapy and balneotherapy for treating low back pain. Five 
randomized clinical trials met all inclusion criteria. Three of them tested the effectiveness of 
spa- and two them tested effectiveness of balneotherapy. The data assessed on a 100mm 
visual analogue scale (VAS), suggest significant beneficial effects compared with control 
groups for patients with chronic low back pain. Results for the Schober index, assessing 
lumbar flexibility, suggested no significant intergroup differences. The methodological 
quality was on average adequate, given that patient blinding was not possible. There was no 
mention of adverse events even though the data are scarce, there is some encouraging 
evidence suggesting that spa therapy and balneotherapy may be effective for treating patients 
with low back pain. The authors encouraged further systematic research. Future studies 
should be randomized, adequate sample sizes should be assessed, ideally administering 
similar regimens under similar conditions [81]. 
Following the metaanalysis by Pittler et al., several trials were conducted in low back 
pain including that one presented in this work. The results of these trials were analyzed in the 
review of Karagülle et al in 2014. This review contained total of eight RCTs and 649 patients. 
The authors used Jadad checklist for methodological quality evaluation of the trials. Only 
three trials were graded as good quality, one balneotherapy trial a score of 5 (our study), and 
two spa therapy trials with score of 3. Two RCTs tested effectiveness of two different 
balneotherapy methods six RCTs examined diverse spa therapy programs for LBP. Across a 
range of outcome measurements assessed in these publications, significant differential 
beneficial effects (most pronounced in reducing pain and improving function) in favor of spa 
therapy and balneotherapy have been shown in short and long terms. The quality of the RCTs 
evaluating balneotherapy and spa therapy for the treatment of low back pain is generally low. 
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They concluded that balneotherapy and spa therapy seem to be beneficial in patients with 
LBP and might be considered as a non-pharmacological therapeutic option, but evidence on 
effectiveness of balneotherapy and spa therapy as therapy options in the treatment of LBP is 
yet insufficient and not conclusive [82]. 
The efficacy of balneotherapy has been most clearly evidenced in gonarthrosis. The 
first randomized, double-blind, tap water-controlled study evaluating the efficacy of 
balneotherapy in patients with knee osteoarthritis was published by Hungarian authors, Szűcs 
et al in 1989. Study participants received thermal mineral water or tap water treatment for 20 
minutes a day on 18 occasions; a decrease in joint pain and tenderness was noted in the 
thermal mineral water-treated group [83]. 
In a multicenter, randomized, controlled trial involving 382 patients with knee 
osteoarthritis published by Forestier et al in 2010, the spa therapy group received massage, 
showers, mud therapy, performed daily standardized exercises, and continued usual medical 
treatments in addition to thermal mineral water bathing. The control group performed daily 
exercises and continued usual medical treatments. The study included a month 6 follow-up 
visit, when visual analog scale, Western Ontario and MC Master Universities Arthritis Index, 
and Short Form (36) self-report questionnaires were used. Combined therapy proved to be 
more effective even during the 6-month follow-up period [84]. 
A Cochrane review published by Verhagen et al in 2008 was based on the analysis of 
7 randomized, controlled trials. Silver level evidence was found concerning balneotherapy in 
osteoarthritis. Because of the poor methodological quality and the absence of an adequate 
statistical analysis and data presentation, the scientific evidence is weak. The authors 
emphasize the need for further additional, confirmatory studies [85]. 
In a systematic review published in 2009, Falagas et al analyzed the results of 
randomized, controlled studies evaluating the efficacy of balneotherapy published between 
1950 and 2006. Results of 29 RCTs regarding balneotherapy in various medical fields were 
analyzed. Twenty-two studies included patients with rheumatologic and musculoskeletal 
diseases. Eight of them were conducted in patients with osteoarthritis. Despite the 
heterogeneous study population of the evaluated RCTs, there seems to be a beneficial effect 
of balneotherapy in the majority of them. The authors suggested that balneotherapy is 
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associated with clinical improvement mainly in rheumatic diseases such as osteoarthritis, 
fibromyalgia, ankylosing spondylitis, rheumatoid arthritis and in chronic low back pain [86]. 
A systematic review published by Harzy et al in 2009 evaluated the short- and long-
term effects of balneotherapy in knee osteoarthritis by analyzing the results of RCTs. The 
results of 9 RCTs were evaluable, including data from 493 patients. All therapies used in 
these trials resulted in decrease of pain and improvement of function and the improvements 
were measurable even after 24 weeks. No serious adverse effects were observed. The authors 
of both reviews suggested that further RCTs should be conducted [87]. 
A systematic review and meta-analysis published by Bender T et al in 2013, analyzed 
the results of studies evaluating the effect of Hungarian thermal mineral waters published by 
Hungarian authors between 1989 and 2012 in the English literature. Out of the 122 studies, 18 
were clinical studies, and 9 of these met the criteria for meta-analysis. Out of these 9 studies, 
4 involved patients with chronic low back pain, 2 with knee and 2 with hand osteoarthritis, 
and 1 with chronic inflammatory pelvic disease. The primary endpoint of the meta-analysis 
was the measurement of the pain-reducing effect of balneotherapy. Regardless of the 
composition of the mineral water, balneotherapy significantly decreased joint pain at rest and 
on exertion in patients with chronic low back pain and knee and hand osteoarthritis [88]. 
 
Assessment of the effects of balneotherapy and the tools of health assessment 
The assessment of a patient suffering from chronic musculoskeletal diseases should 
include evaluations of pain, function, and quality of life. Global pain or disability can also be 
evaluated using a visual analog scale (VAS). A patient reported outcome (PRO) is a method or 
questionnaire used in a clinical trial or a clinical setting where the responses are collected directly 
from the patient. The PROs provide intrinsic knowledge about a patient’s health, functional status, 
symptoms, treatment preferences, satisfaction, and quality of life.  
When measuring treatment effect in osteoarthritis/chronic low back pain with multi-item 
outcome instruments, it is necessary, both for clinical decision-making and research purposes, to 
understand the clinical importance of the outcome scores. The minimal clinically important 
improvement (MCII), defined as the smallest change in measurement that signifies an important 
improvement in a patient’s symptom. Tubach et al in a prospective cohort study aimed at 
estimating the MCII from the patient’s perspective for three main patient reported outcomes used 
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in OA trials: pain, patient’s global assessment of disease activity (measured on visual analogue 
scales 0-100 mm), and functional impairment (measured on the Western Ontario McMaster 
Universities Osteoarthritis Index function subscale 0-100). For knee OA MCII for absolute (and 
relative) changes were, respectively, -19.9 mm for pain; -18.3 mm for patient’s global assessment; 
-9.1 for WOMAC function subscale score [89]. 
Hagg O et al aimed to estimate the minimal clinically important difference of three multi-
item outcome instruments (the Oswestry Disability Index, the General Function Score and the 
Zung Depression Scale) and of the VAS of back pain. The study population consisted of 289 
patients treated surgically or non-surgically in a randomised controlled trial. The minimal 
clinically important difference of VAS back pain was 18-19 units. The minimal clinically 
important difference was 10 units for Oswetry Disability index score [90]. 
The Western Ontario and MC Master Universities Arthritis Index (WOMAC) is 
often used, standardized questionnaires to appreciate condition of patient with OA of the knee and 
the hip, including pain, stiffness, and physical functioning of the joints. The WOMAC measures 5 
items for pain, 2 for stiffness, and 17 for functional limitation. Physical functioning questions 
cover everyday activities. The WOMAC has been used in both observational/epidemiological 
studies and to examine changes following treatments including pharmacotherapy, arthroplasty, 
exercise, physical therapy, knee bracing, and acupuncture. Higher scores on the WOMAC 
indicate worse pain, stiffness, and functional limitations [91]. Study has shown that WOMAC and 
SF-36 subscales with similar constructs have moderate to high correlations [92]. The WOMAC 
has shown significant correlations with performance scores for walking, stair climbing, rising 
from a chair, and joint range of motion among older adults with knee and hip OA. [93]. The 
WOMAC is validated in Hungarian [94]. 
 The Health Assessment Questionnaire (HAQ) is based on five patient centered 
dimensions: disability, pain, medication effects, costs of care, and mortality. Typically, one of two 
HAQ versions is used: the Full HAQ, which assesses all five dimensions, and the Short or 2-page 
HAQ, which contains only the HAQ disability index (HAQ-DI) and the HAQ’s patient global and 
pain visual analog scales (VAS) [95]. The HAQ-DI has also been administered in a variety of 
diseases and conditions, including osteoarthritis, juvenile rheumatoid arthritis, systemic lupus 
erythematosus, ankylosing spondylitis, fibromyalgia, psoriatic arthritis, and systemic sclerosis 
[96]. HAQ was compared with WOMAC and was found to be similarly and significantly 
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correlated [97]. The HAQ-DI, assesses a patient’s level of functional ability and includes 
questions of fine movements of the upper extremity, locomotor activities of the lower extremity, 
and activities that involve both upper and lower extremities. Standard scoring takes into account 
the use of aids and devices or assistance from another person. There are 20 items in eight 
categories that represent a comprehensive set of functional activities – dressing, rising, eating, 
walking, hygiene, reach, grip, and usual activities. For each item, there is a four-level response set 
that is scored from 0 to 3, with higher scores indicating more disability. To calculate the HAQ-DI, 
the highest subcategory score determines the value for each category. The category scores are 
then averaged into an overall HAQ-DI from zero to three. Scores of 0 to 1 generally represent 
mild to moderate difficulty, 1 to 2 represent moderate to severe disability, and 2 to 3 indicate 
severe to very severe disability [95]. The HAQ-DI is validated in Hungarian [98]. 
The Oswestry Disability Index (ODI) is an index originated from the Oswestry Low 
Back Pain Questionnaire to quantify disability for low back pain. The self-completed 
questionnaire includes ten topics related intensity of pain, lifting, ability to care for oneself, ability 
to walk, ability to sit, sexual function, ability to stand, social life, sleep quality, and ability to 
travel. Each topic category is followed by 6 statements describing different potential scenarios in 
the patient's life relating to the topic. Each question is scored on a scale of 0-5 with the first 
statement being zero and indicating the least amount of disability and the last statement is scored 
5 indicating most severe disability. The scores for all questions answered are summed then 
multiplied by two to obtain the index (range 0 to 100). 0 to 20: Minimal disability, 21-40: 
Moderate Disability, 41-60: Severe Disability, 61-80: Crippling back pain, 81-100: These patients 
are either bed-bound or have an exaggeration of their symptoms [99]. The ODI is validated in 
Hungarian [100]. 
The Short Form (36) (SF-36) is an all-purpose, short-form patient reported health survey 
with 36 questions. The SF-36 has proven useful in surveys of general and specific populations, 
comparing the relative burden of diseases, and in differentiating the health benefits produced by a 
wide range of different treatments. The SF-36 has undergone modifications. The Version 2.0 five-
level response scales substantially improve the two SF-36 role functioning scales. The SF-36 is 
available in both standard (4-week) and acute (1-week) recall versions. The SF-36 consists of 
eight scaled scores, which are the weighted sums of the questions in their section. Each scale is 
directly transformed into a 0-100 scale on the assumption that each question carries equal weight. 
  
25 
The higher the score the less disability i.e., a score of zero is equivalent to maximum disability 
and a score of 100 is equivalent to no disability. The eight sections are: Vitality - V, Physical 
Functioning - PF, Role Physical - RF, Bodily Pain - BP, General Health - GH, Role Emotional - 
RE, Social Functioning - SF, Mental Health - MH. Three scales (PF, RP, BP) correlate most 
highly with the physical component and contribute most to the scoring of the Physical Component 
Summary (PCS) measure. The mental component correlates most highly with the MH, RE, and 
SF scales, which also contribute most to the scoring of the Mental Component Summary (MCS) 
measure. Three of the scales (VT, GH, and SF) have noteworthy correlations with both 
components [101]. The SF-36 is validated in Hungarian [102]. 
The EuroQoL five dimensions questionnaire (EQ-5D-3L) “essentially consists of the 
EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS). The EQ-5D-3L 
descriptive system contains the following 5 dimensions: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression. Each dimension has 3 levels: no problems, some 
problems, extreme problems. A unique health state is defined by combining 1 level from each of 
the 5 dimensions. A total of 243 possible health states are defined in this way. Each state is 
referred to in terms of a 5 digit code. EQ-5D health states, defined by the EQ-5D descriptive 
system, may be converted into a single summary index by applying a formula that essentially 
attaches values to each of the levels in each dimension. The EQ VAS records the respondent’s 
self-rated health on a vertical, visual analogue scale where the endpoints are labelled “Best 
imaginable health state” and “Worst imaginable health state”. The EQ-5D-3L (EQ-5D 3 level) 
self-complete paper version is currently translated in more than 170 language versions” [103]. 
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AIMS OF THE THESIS 
Metaanalyses and review studies on the efficacy of balneotherapy evaluated the 
analyzed randomized, controlled trials as of inappropriate methodology. Therefore, we aimed 
to design our studies with appropriate methodology, in accordance with the recommendations 
for study planning. These trials may provide data for a more precise evaluation of the role of 
balneotherapy in the management of each condition. 
 
I. Our aim was to evaluate the effectiveness of thermal mineral water compared with tap 
water and supplementary electrotherapy in patients with chronic low back pain first in the 
English literature in a double-blind trial. As primary endpoint, we aimed to monitor changes 
in low back pain, movement functions, and quality of life of the enrolled patients. Secondary 
end-points were to record changes in the dose requirements of analgesics and explore the 
safety profile of treatment. 
 
II. There have been several publications about the use of balneotherapy in knee osteoarthritis. 
The effect of balneotherapy on hand osteoarthritis has not yet been studied. Our aim was to 
evaluate the efficacy of thermal water, mineral water, and supplementary magnetotherapy in 
patients with hand osteoarthritis. The primary endpoint was the effect of balneotherapy on 
hand pain, hand functions, and quality of life. As secondary endpoint, we assessed whether 
there is any clinically significant, evaluable difference in the effect of waters of different 
temperature.  
 
III. Studies involving patients with knee osteoarthritis and systematic reviews confirmed the 
analgesic and knee function improving effect of balneotherapy. However, in most of the 
studies, bath therapy was combined with other therapies. Furthermore, only a limited number 
of previous studies covered the assessment of quality of life. Therefore, the primary endpoint 
of the study was the evaluation and documenting of the pain-reducing effect of Lake Hévíz 
thermal mineral water on knee pain at rest or on exertion in patients with mild to moderate 
knee osteoarthritis as well as the assessment of the therapeutic effect compared to the control 
group treated with warmed tap water. The secondary endpoints included the evaluation of the 
effect of Lake Hévíz thermal mineral water on knee function and quality of life.
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I. EFFECT OF THERMAL WATER AND ADJUNCTIVE ELECTROTHERAPY ON 
CHRONIC LOW BACK PAIN: A DOUBLE-BLIND, RANDOMIZED, FOLLOW-UP 
STUDY 
 
OBJECTIVES 
The number of studies on the effects of thermal water in the treatment of chronic low 
back pain is relatively small. The first meta-analysis available in English [81] evaluated pooled 
data from only 5 studies [104,105,106,107,108]. The first single-blind study [109] was 
published concomitantly with the above meta-analysis. No double-blind studies have been 
reported so far. The aim of the current study was to evaluate the effectiveness of thermal 
mineral water compared with tap water in the treatment of patients with low back pain, with 
pain level, mobility and quality of life as primary end-points. Secondary end-points were to 
record changes in the dose requirements of analgesics and explore the safety profile of 
treatment. 
 
MATERIALS AND METHODS 
Design 
In this randomized, controlled, double-blind, follow-up study, we evaluated the effects 
of thermal mineral water and adjunctive electrotherapy on chronic low back pain. This study 
was implemented in observance of the rules of good clinical practice. The study protocol was 
approved by the Regional Research Ethics Committee. 
 
Participants  
Male and female patients aged 25–70 years living in and around the town of Celldömölk 
who presented with chronic lumbar pain of more than 12 weeks’ duration were included in the 
study. Subjects were recruited by 3 local general practitioners (GPs). The three GPs and the 
investigators cross-checked the inclusion and exclusion criteria among themselves before the 
launch of the study. The GPs invited patients with chronic lumbar pain to participate in the 
study. Enrolled patients completed the balneotherapy treatment as outpatients, with no change 
in their daily routine or work attendance. The GPs were on call to deal with potential adverse 
reactions or other treatment- related problems. All subjects were informed about the purpose, 
conditions and course of the study prior to inclusion. Patients were given written explanation of 
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the treatment prior to giving their written informed consent. Patients with the following 
conditions were excluded from the study: acute pain; acute organic neurological deficit 
accompanying low back pain; confirmed osteoporosis, neoplastic or inflammatory lesion as the 
underlying cause of low back pain; decompensated cardiovascular disease; unstable 
hypertension, angina pectoris; uncontrolled endocrine disease (hyperthyroidism, 
hyperparathyroidism); other uncontrolled and unstable metabolic disorders (diabetes mellitus, 
hyperuricaemia, hyperlipoproteinaemia); acute febrile infections; cutaneous suppuration; 
pregnancy; decompensated psychosis/neurosis. Patients who had received any kind of 
physiotherapy during the 3-month period prior to the study were similarly excluded. 
 
Study procedures 
The study was conducted at the spa of Celldömölk in Hungary, which opened in 2005. 
Patients were randomized into either of the 2 treatment groups. One group was treated with 
thermal water, whereas the other group was treated with tap water. The water temperature was 
34°C for both groups. Subjects underwent 20-min balneotherapy sessions daily for 3 weeks. 
Both treatment groups received additional electrotherapy under standardized conditions. 
Diadynamic current (long period current with waist electrodes of standard size, and discharge 
duration of 3 min) was applied 3 times per week, before the balneotherapy sessions. The 
patients were monitored continuously during the treatment sessions. The study protocol 
required patients to attend at least 80% of treatments, i.e. a minimum of 17 balneotherapy 
sessions. Baseline and post-balneotherapy assessments were performed by either of 2 
rheumatologists. The rheumatologists standardized the methodology of the measurements and 
tests by jointly examining nonparticipating patients prior to the study. The subjects were 
assessed 3 times: at baseline, after 3 weeks and after 15 weeks. 
 
Randomization and blinding 
Randomization was performed by an individual who was not involved in the 
implementation of the study. It was a simple randomization with a random-number table. 
Except for the bath attendants, neither the subjects, nor the investigators were aware of the 
randomly assigned treatment. The investigators examined the study subjects simultaneously, but 
in different offices. On the first occasion, patients were randomly assigned to an investigator. 
Subsequently, however, every investigator assessed the same subjects he/she had examined at 
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the first visit. The professional performing the statistical analysis was aware of the 
randomization. 
 
Evaluations 
The properties of low back pain were appraised using 100-mm visual analogue scales 
(VAS), as follows. VAS I: the severity of low back pain at rest, as rated by the patient. VAS II: 
the severity of low back pain upon exertion, as rated by the patient. VAS III: perceived status, 
as rated by the patient. VAS IV: the patient's progress, as rated by the investigator. The range of 
mobility of the lumbar spine was estimated by performing Schober’s test and the Domján R and 
L tests (the right, left lateral flexion of the lumbar spine in cm) [110]. The Oswestry Disability 
Index was used to assess the functions of the lumbar spine. The subjects’ quality of life was 
evaluated with the SF-36 questionnaire. 
 
Thermal water composition 
The water source used was the well “Cell-4” at Vulcan Spa, Celldömölk, Hungary. This 
is a very mild mineral water rich in solutes (sodium hydrogen carbonate and chloride), also 
containing fluoride and a substantial amount of iodides (Table 1.). The appearance of the tap 
water was changed to resemble that of the thermal water; through the addition of extract of 
green walnut husks. The characteristic smell of the thermal water was simulated by using 
bathtubs located in the same hall as the treatments with thermal water were undertaken. 
 
Table 1. Mineral composition of thermal water 
Total hardness of water  12 mg/CaO/l  
Total solute content  3350 mg/l  
Cations mg/l Anions mg/l 
Sodium 950l Chlorine 530 
Potassium 5.9 Iodides 0.66 
Calcium 5.5 Hydrogen carbonate 1600 
Magnesium 1.7 Fluoride 6.5 
 
Statistical methods 
Data were entered into and analysed with MS Excel software. Statistical comparisons 
were made using single-sample (paired) and 2-sample t-tests. Intention-to-treat (ITT) analysis 
was performed. All patients were taken into account upon evaluation of the results. 
Retrospectively, the likelihood of absenteeism from study visits was not related to the absolute 
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value of missing data and accordingly, these could be regarded as incidental deficiencies. 
Missing data of drop-outs were substituted with the last measured value in order to avoid over-
estimation of the therapeutic effect. A separate analysis (a per protocol (PP) analysis) was 
carried out for patients who completed the full treatment course in compliance with study 
requirements. This afforded approximate assessment of efficacy variables following 
intervention under optimal circumstances. The level of significance was set at p < 0.05. 
 
RESULTS 
Recruitment of patients began in January 2007 and the study was launched at the end 
of February 2007. Of the 71 patients included in the study, 64 completed more than 80% of 
the therapy course. Demographic and baseline clinical characteristics of patients in the ITT 
population are shown in Table 2. 
 
Table 2. Demographic data and other baseline clinical characteristics of the patients by 
treatment group 
 Thermal water group (n = 36) Control group (n= 35 ) 
Postoperative condition 6 7 
No. male/female 23/13 23/12 
Age, years mean (SD) 57.6 (7.9) 56.3 (7.5) 
 
The 2 treatment groups were similar with regard to demographic data and baseline 
clinical characteristics. Seven patients discontinued the treatment period after 3 weeks 
(5 patients in the thermal group, and 2 patients in the tap water group). A further 13 patients 
(2 from the thermal water group and 11 from the control group) did not return for the 15-week 
control visit. The disposition of the patients is presented in Figure 1. 
 
Figure 1. Disposition of the patients 
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ITT analysis at the end of 3 weeks treatment revealed a decrease in VAS scores for both 
groups. Within-group comparison to baseline showed significant improvement of pain at rest  
(VAS I p < 0.01), lumbar pain on exertion (VAS II p < 0.01), perceived status as rated by the subjects 
(VAS III p < 0.01), as well as the patient’s general condition as rated by the investigator (VAS IV 
p < 0.01) for both treatment groups. The improvement remained significant for all 4 parameters after 
15 weeks in the group treated with thermal water (p < 0.01). In the control group only 2 parameters, 
VAS II and VAS IV scores remained significantly (p < 0.05) improved after 15 weeks. 
Between-group analysis gave the following results. Within the 3-week study interval 
patients receiving thermal water therapy showed a significant therapeutic response, with a decrease 
in VAS IV scores compared with the control group (–14.8 (95% CI –18.9 to –10.7)  
vs –8.2 (95% CI –14.1 to –2.4) p < 0.05). After week 15, the changes in VAS III scores between 
baseline and the end of the study were significantly greater in the thermal water group (–17.6 (95% 
CI –22.9 to –12.4) vs –5.2 (95% CI –13.9 to 3.4) p < 0.05). 
A similar trend was revealed by the results of the tests evaluating the range of motion of the 
lumbar spine (Schober’s, Domján’s R-L, Oswestry). While the improvement shown by these 4 tests 
was still statistically significant after 3 weeks in the thermal water group, only the Domján R and L 
tests remained significantly improved in the control group (p < 0.05). 
After week 15, however, only Domján L and Oswestry scores of the thermal water group 
were significantly superior compared with baseline values (p < 0.05). At the end of 3 weeks, there 
was no significant difference when comparing the test results between the thermal water and the 
control group. Significant improvement was seen after week 15 in the Schober’s index in the 
thermal water group compared with the control group (0.08 (95% CI –1.12 to 1.29)  
vs –1.79 (95% CI –3.09 to –0.48) p < 0.05). 
By the end of week 3 quality of life indicators, SF-36 items (PF: Physical Functioning, RP: 
Role Physical, BP: Bodily Pain, GH: General Health, V: Vitality, SF: Social Functioning, RE: Role 
Emotional, MH: Mental Health) improved significantly both in the thermal water and in the control 
group (p < 0.01) compared with baseline. The improvement in quality of life compared with 
baseline remained significant for both groups after 15 weeks. Although the improvement after week 
15 was still significant compared with baseline, as shown by the PF, RP, BP, GH, V, RE items in 
the thermal water group (p < 0.01) and by the RP, V, RE items in the control group (p < 0.05), the 
outcome status of the 2 groups was not statistically different. 
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The 2 groups were also compared for patients who completed the full treatment course 
according to the study protocol. A total of 51 patients (29 in the thermal water and 22 in the control 
group) were analysed separately (PP analysis). The results were consistent with those of the ITT 
analysis, but between-group differences and the extent of the therapeutic response showed 
significantly greater improvement in the thermal water group. Means and 95% CI are shown in 
Table III. After 3 weeks, significant between-group differences were seen in the changes of VAS IV 
scores, in Schober’s and Oswestry, as well as in SF-36 BP (p < 0.05). After week 15, however, the 
thermal water group proved significantly superior to controls with regards to the changes in VAS I 
scores, Schober’s, and Domján’s L indices compared with their baseline values (p < 0.05). After 
week 15, none of the SF-36 parameters indicated a significant change in the control group. 
Comparison of the 2 groups showed that the improvement of PF after week 15 was significantly 
greater in the thermal water group than in controls (p < 0.05). 
No adverse reactions were observed during treatment sessions or during the whole study 
period. Potential changes in the efficacy of analgesic therapy could not be monitored, due to the 
small number of subjects who took analgesics regularly; statistical analysis of this parameter 
therefore proved unfeasible. 
 
DISCUSSION 
Overall, study parameters indicated a tendency for positive physiological changes in both 
groups. In the group treated with thermal water, improvement occurred earlier, lasted longer, and 
was statistically significant in more patients, both in within-group and in between-group 
comparisons. Compared with controls, however, the statistically significant difference (in VAS 
III, VAS IV scores and Schober’s index) between the groups was smaller than the (more 
substantial) improvement expected on theoretical grounds. While the analgesic effect of thermal 
water is well known, the short-term relief seen among controls emphasizes the beneficial, relaxing 
effect of hydrotherapy with hot water [8]. In contrast to the ITT analysis, the PP analysis 
demonstrated the advantage of the thermal water group over controls, as reflected by the 
improvement in a greater number of study parameters (VAS IV, Schober’s, Oswestry, SF-36 BP 
on week 3 and VAS I, Schober’s, Domján L, SF-36 PF on week 15). Evidently, the statistical 
power of the PP analysis is weaker in a double-blind placebo-controlled trial; however, presenting 
the results of patients who have completed the study in compliance with the protocol was deemed 
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important, to demonstrate the statistical significance of differences in addition to the statistical 
trend revealed. The first controlled, double-blind study of balneotherapy was reported in the 
literature by Hungarian authors in 1989 [83]. Since that time, an increasing number of papers have 
been published on the favorable effects of balneotherapy in a variety of musculoskeletal disorders 
including rheumatoid arthritis [111], ankylosing spondylitis [112], osteoarthritis [113,114] and 
fibromyalgia [115]. The majority of papers regard treatment with thermal water as an element of 
complex therapy, although there are also reports on monotherapy. Several papers have discussed 
the methods developed for measuring the efficacy of spa therapy [116,117]. In contrast to 
previous appraisals of spa therapy, our study compared thermal water with tap water, and not with 
pharmacotherapy of other treatment modalities. In our study, adjunctive electrotherapy did not 
exert any substantial analgesic effect. Only a few studies have investigated the effects of 
diadynamic current [118]. According to the tap water-controlled, single-blind study of Balogh et 
al, long-term relief of pain, muscle spasm and tenderness of paravertebral muscles, as well as the 
improvement of the range of motion of the lumbar spine was significant in the group treated with 
thermal water (containing sulphur) only [109]. 
In their study on outpatients undergoing therapy for low back pain, Konrad et al [107] 
reported the results of treatment with 3 different modalities (thermal water, underwater jet 
massage, weight bath) in comparison with untreated controls. All 3 groups on active treatment 
improved, and one year later their analgesic dose requirements were lower than that of controls. 
Guillemin et al. compared the effects of 3-week balneotherapy (15-min underwater jet 
massage in 36°C water, followed by 3-min showering with water of 31–36°C temperature) with 
that of outpatient management, in patients with low back pain. Analgesic use (upon prescription 
by the family practitioner) was allowed in both groups, but other modalities of physiotherapy 
were not. Assessments were undertaken at baseline, on day 26 of treatment, and 9 months after 
the end of therapy. Compared with controls, the improvement of several parameters (VAS score, 
Schober’s sign, lumbar spine mobility, reduction of analgesic requirements) was evident 
immediately after treatment, and (except for the Waddell disability score) proved lasting even 9 
months later [104]. 
Another French study randomized 121 patients with low back pain into 2 groups treated 
with either balneotherapy (for 10 min, followed by packing with 45°C mud for 20 min., and then, 
high-pressure showering for 2.5 min.) or with pharmacotherapy only. Study parameters 
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(Schober’s index, finger-floor distance, pain scale scores, Roland & Morris Disability 
Questionnaire, analgesic requirements) were substantially improved immediately after treatment 
and 6 months later, thereby demonstrating the long-term effect of balneotherapy [105]. 
According to Constant et al [106], spa therapy enhanced the quality of life evaluated with 
the Duke Health Profile Questionnaire of 128 treated patients (compared with that of 96 controls) 
and improvement persisted 3 months later. 
In 2006 we reported the results of our pilot study. This randomised, single-blind, 
controlled, follow up study included 42 patients with chronic low back randomly assigned into 
three groups. In group I subjects (n=20) bathed in Lake Hévíz, and in group II (n=11) patients 
were treated in a pool full of thermal-mineral water, the third group (n=11) received hydrotherapy 
in a pool of tap water. Participants underwent 30 minutes therapy sessions, every 1-3 days, on 15 
occasions. At the start and at the end of the treatment: all participants completed a quality of life 
and daily life functions questionnaire (SF-36), and short test for measuring depression (Beck 
Depression Inventory) and the Oswestry Disability Index questionnaire. The patients’ pain was 
recorded by using visual analog scale score. 3 and 6 months after starting treatment the SF-36 
questionnaires were repeated. Within-group comparison to baseline showed significant 
improvement of lumbar pain as rated by the subjects in all groups. Statistically significant 
improvement was observed in lumbar pain parameter after the treatment in the thermal-mineral 
water groups versus the group III. The responders' self-rated health measured on the Beck 
Depression Inventory and Oswestry Disability Index scale slightly improved, but the changes 
were not statistically significant in the three groups. Because of the small number of cases 
evaluation of the SF-36 data only in the group I (Lake Hévíz) were processed. After the treatment 
and during the 3 months follow-up period all SF-36 items improved significantly in the group I 
compared with baseline. During 6 months follow-up, all the SF-36 parameter decreased to the 
baseline values [119]. 
In 2012 published randomised, single-blind, follow-up study, Tefner et al compared the 
effects of 15 sessions of balneotherapy with tap water in outpatients with low back pain. 
Assessments were undertaken at baseline, week 3, week 6 and week 13. By the end of the 
balneotherapy course, the VAS score of low back pain, mobility of the lumbar spine (reflected by 
lumbar Schober’s sign and lateral flexion in both directions) and Oswestry Disability Index, 
EuroQol-5D index, all components of the SF-36 questionnaire (except for the components 
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indicative of general health and social functioning) improved significantly in the treatment group, 
compared to baseline. These improvements persisted until the end of follow-up. By contrast, no 
significant changes occurred in the control group. Between-group differences in the above 
parameters were significant both at the end of balneotherapy and during follow-up. In the 
treatment group, the consumption of analgesics and NSAIDs necessary to relieve chronic low 
back pain decreased significantly by the end of balneotherapy, and this reduction remained 
significant until the end of follow-up [120]. Their study is well comparable with our trial in 
treatment duration and similar outcome parameters. Although a much greater improvement was 
observed in their study than in ours, it can be attributed in part to the high mineral content of the 
applied thermal-mineral water and in part to the single-blind design of the study. 
Also in 2012 published paper, Kesiktas et al compared the effect of combined physical 
therapy (transcutaneous electrical nerve stimulation, ultrasound, infrared radiation combined with 
back education program and exercise) with balneotherapy and same back education, and exercise 
programs. Significant improvements in back extensor muscle test, lumbar flexibility (Schober’s 
test), functional capacity (ODI), and quality of life (SF-36) and reduction in pain severity were 
found in both groups. These effects persisted even improved in spa therapy group 3 months later 
but this was not significantly different than physiotherapy group. Comparing the two groups at 3-
month spa therapy had significant superiority to physical therapy in improving quality of life and 
flexibility of patients [121]. Gremeaux et al in a randomized prospective alternate-month design-
type study recruited 360 outpatients with chronic low back pain. Intervention group underwent a 
spa therapy program for 3 weeks including 15 sessions of mud pack at 45 °C for 20 min, 
supervised mobilization in a mineral water pool at 33 °C, 15 min, and waterspouts in the pool 10 
min, and hydrojet 10 min 5 days/week combined with three standardized education workshops 
every week lasting an hour and a half each. Control group had same spa therapy and non-
standardized verbal information. According to the results they found a significant reduction in the 
physical fear avoidance beliefs score at 6 months in both study groups, and this reduction was 
more marked in the spa therapy group including education workshops. Disability (Quebec Scale) 
and pain intensity significantly decreased in both groups, with no difference between groups [122].  
Our study compared thermal water with tap water, and not with pharmacotherapy of other 
treatment modalities. By doing so, medicinal water containing mineral solutes was shown to be a 
more effective treatment than tap water, which exerts physical only effects. 
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Table 3. Statistical analysis of changes over 3 and 15 weeks, compared to baseline; comparison of the nature of changes and of treatment groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results yielded by the per protocol analysis and at variance with those of the intention to treat analysis.
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II. EVALUATION OF THE EFFECT OF BALNEOTHERAPY IN PATIENTS WITH 
OSTEOARTHRITIS OF THE HANDS, A SINGLE-BLIND, RANDOMIZED, 
CONTROLLED FOLLOW-UP STUDY 
This trial was performed in co-operation and under shared lead authorship with Katalin 
Horváth. Katalin Horváth as former rheumatologist at Gunarasfürdő was responsible for patient 
enrollment and coordination. I acted as independent investigator in the trial; this publication has 
been jointly prepared by both of us. 
 
OBJECTIVES 
There have been several publications about the use of balneotherapy in osteoarthritis. The 
majority of these publications describe the treatment of knee osteoarthritis. Therapeutic 
recommendations mention a broad scale of non-pharmacological conservative treatment options. 
Our primary objective was to evaluate how Gunaras thermal mineral water therapy influences 
pain, hand function and quality of life in patients with hand osteoarthritis compared with the 
control group. The secondary objective of the study was to evaluate whether different water 
temperatures influence clinical parameters. 
 
MATERIALS AND METHODS 
Design 
This was a randomized single-blind three-arm parallel-group controlled follow-up study. 
It was conducted in accordance with the Declaration of Helsinki, International Conference on 
Harmonization – good clinical practice standards and was approved by the Regional Research 
Ethics Committee (Approval No. 316-25031/KK41/2009). 
 
Participants 
All subjects were informed about the purpose, conditions and course of the study prior to 
inclusion. Patients have read and understood the Patient Information Sheet and have signed the 
Informed Consent Form. The study was planned and conducted in accordance with the guidelines 
of the Osteoarthritis Research Society International [123] regarding hand osteoarthritis. Male and 
female patients between 50 and 70 years of age with moderate to mild osteoarthritis of the hands 
meeting the American College of Rheumatology classification criteria regarding hand 
osteoarthritis that has been confirmed by radiological assessments (comparative radiograph of the 
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hands) and who have hand pain characteristic of osteoarthritis of the hands for at least three 
months [124] were included in the study. Patients with the following diseases or conditions were 
excluded from the study: conditions or diseases contraindicating hot bath treatment, every severe 
diseases affecting the internal organs, the urogenital tract or the skin, infection or fever when bath 
treatment is contraindicated; non-steroid anti-inflammatory or chondroprotective therapy that was 
changed within one month prior to the initiation of study treatment or during study treatment; 
intraarticular corticosteroid injection administered within one month prior to the initiation of study 
treatment or during study treatment; inflammatory rheumatic disease (rheumatoid arthritis, 
ankylosing spondylitis, psoriatic arthritis, crystal arthropathy, etc.) or carpal tunnel syndrome, 
tenosynovitis or fibromyalgia syndrome; hand injury or hand surgery within six months prior to 
the study; and any fractures of the hand. Also excluded were non-cooperative patients and patients 
with inadequate mental or psychic condition. Patients who had received any kind of physical 
therapy during the three-month period prior to the study were also excluded. 
 
Study procedures 
The study site was Gunaras bath, located 2 km from Dombóvár, a small West 
Transdanubian town in Hungary. Recruitment of patients started in February 2010, whereas the 
study was launched at the end of May 2010. Patients were enrolled by the rheumatologist of 
Gunaras Health Spa from the population visiting the rheumatology specialist clinic of Gunaras 
Health Spa or from patients referred to the spa by general practitioners who received an 
information leaflet about the study. Enrollment was in conformity with the inclusion and 
exclusion criteria. The patients were examined by an independent rheumatologist. Enrolled 
patients completed the balneotherapy treatment as outpatients, with no change in their daily 
routine or work attendance. The patients were monitored continuously during the treatment 
sessions. Patients completing more than 80% of the treatments were considered to have 
completed the study. Baseline and post-balneotherapy assessments were performed by an 
independent rheumatologist. Patients were randomized into three treatment groups. All three 
groups received standard pulsed magnetic field therapy (60 Hz, 20 J, 15 minutes) applied on the 
hands three times weekly for three weeks. In addition, the patients in two groups bathed by 
immersion of the body (head-out immersion) in 36°C or 38°C thermal mineral water (group 1 and 
group 2, respectively). The subjects in these groups underwent 20 minutes balneotherapy sessions 
five times weekly for three weeks.  
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Randomization and blinding 
The patients were randomly assigned into three groups following simple randomization 
with a computer-generated sequence. The randomizer was not involved in the implementation of 
the study. The randomizer received the information about the patients by via mail. Corresponding 
envelopes were opened only after the enrolled participants completed all baseline assessments and 
it was time to allocate the intervention. The professional performing the statistical analysis was 
aware of the randomization. The examiner was blinded regarding the received therapy.  
 
Evaluations 
The primary outcome measures were visual analogue scale scores, handgrip strength, 
pinchgrip strength, the number of swollen and tender joints of the hand, the duration of morning 
joint stiffness, HAQ and SF-36 questionnaire. The subjects were assessed three times: at baseline, 
after three weeks and after 13 weeks. A 100mm VAS was used to record the pain in small joints 
of the hand, as follows: VAS I: the severity of pain in the small joints of the hands at rest, as rated 
by the patient. VAS II: the severity of pain in the small joints of the hands upon exertion, as rated 
by the patient. VAS III: patient’s global assessment of hand status. VAS IV: physician’s global 
assessment of hand status. For both hands, grip strength and two podpinch strength (thumb and 
index finger) were measured in kilograms by the Saehan Hydraulic Hand Dynamometer (Model 
SH5001) with the subjects sitting in a standard position with the elbow in 90° flexion and the 
wrist in a neutral position [125]. The mean of the five registrations was recorded. The number of 
swollen and tender joints and the duration of morning stiffness of the small joints of the hands 
were recorded. The HAQ was used to assess the function of the hand. The subjects’ quality of life 
was evaluated with the SF-36 questionnaire. We presented from the SF-36 subscales the norm-
based physical component summary (PCS) and mental component summary (MCS) scores. 
 
Thermal water composition 
The thermal mineral water is an alkaline sodium hydrogen carbonate containing soft 
water that contains significant amounts of fluoride. Its total mineral content was 2210 mg/L, 
its temperature was 36°C in one group (group 1) and 38°C in the other group (group 2). The 
characteristics and mineral composition of the thermal water are shown in Table 4. 
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Table 4. Characteristics and mineral composition of thermal water 
Total solute mineral 2110 mg/l 
Total organic content  3.1 mg/l 
Total hardness of water 11.0 CaO mg/l 
pH 8.0 
Water temperature 36 oC/38oC 
Cations mg/l Anions mg/l 
Sodium 610 Chlorine 72 
Potassium 5 Bromine 0.707 
Ammonium 8.8 Iodine 0.16 
Calcium 4.1 Fluorine 2.96 
Magnesium 0.8 Sulphate 27 
Iron 0.05 Hydrogen carbonate 1403 
Lithium 0.07 Sulphide 0.18 
 
Statistical analysis 
Data were entered into and analysed with MS Excel and SPSS software. Statistical 
comparisons were made using ANOVA and as post-hoc tests Scheffe´ and Dunnett.  
Intention-to-treat (ITT) analysis was performed. Probability (p) values below 0.05 were 
considered significant. 
 
RESULTS 
Of the 63 patients included in the study, 59 completed more than 80% of the therapy 
course. Demographic and baseline clinical characteristics of patients are shown in Table 5.  
 
Table 5. Demographic data and other baseline clinical characteristics of the patients by treatment group 
 Thermal water 36 °C Thermal water38 °C Control 
Enrolled, male/female n = 21, 4/17 n = 21, 5/16 n = 21, 3/18 
 Mean (SD) Mean (SD) Mean (SD) 
BMI  29.4 (3.5) 26.9 (4.1) 28.9 (5.4) 
Age 63.5 (4.7) 62.3 (4.8) 63.8 (4.4) 
Duration of symptoms (years) 16.4 (12.7) 10.3 (11.6) 11.7 (9.9) 
Right-handed / left-handed 20/1 20/1 20/0 
VAS I 34.8 (20.7) 29.7 (22.8) 31.9 (23.8) 
VAS II 57.8 (22.9) 54.8 (24.6) 51.9 (23.8) 
VAS III 50.4 (15.0) 48.5 (19.4) 47.6 (20.2) 
VAS IV 46.1 (15.1) 49.8 (17.8) 42.8 (15.7) 
Grip strength right hand (kg) 17.5 (7.5) 21.4 (11.5) 17.3 (8.1) 
Grip strength left hand (kg) 15.9 (7.4) 19.4 (10.7) 15.3 (8.1) 
Pinch strength right hand (kg) 2.9 (1.5) 3.3 (2.5) 2.9 (1.2) 
Pinch strength left hand (kg) 2.7 (1.1) 2.96 (1.7) 2.4 (1.1) 
HAQ 1.0 (0.4) 0.99 (0.5) 0.8 (0.5) 
Morning joint stiffness (min) 9.7 (7.9) 12.4 (17.2) 9.4 (8.6) 
Swollen joint count 3.0 (2.1) 3.4 (2.6) 2.1 (2.3) 
Tender joint count 7.1 (4.9) 8.3 (4.4) 5.5 (4.5) 
PCS (Physical Component Summary) 37.4 (6.6) 37.5 (6.1) 39.7 (6.7) SF-36 MCS (Mental Component Summary) 39.6 (9.4) 42.3 (6.3) 41.0 (8.0) 
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The treatment groups were similar with regard to demographic data and baseline 
clinical characteristics. All study patients except two were right-handed. Four patients 
discontinued the treatment period after three weeks (two patients in the thermal group I 
(36°C), and two patients in the control group). The disposition of the patients is presented in 
Figure 2. 
 
Figure 2. Disposition of the patients 
 
 
Examination of the hands revealed an improvement in the subjective parameters 
measured by VAS scale in all study groups. After the three-week treatment, patients receiving 
36°C thermal water therapy showed a significant therapeutic response compared with the 
control group, with a decrease in VAS I (-28.9 (95% CI -38.2 to -19.5) vs. 11.4 (95% CI -19.1 
to -3.8), p<0.05) and VAS II (-28.2 (95% CI 36.5 to -19.9) vs.-9.95 (95% CI -20.1 to 0.2), 
p<0.05) scores. In patients treated with 38°C water, VAS IV score showed a similar statistical 
effect compared with the control group (-14.6 (95% CI –19.9 to -9.2)  
vs. -3.0 (95% CI -5.9 to -0.1), p<0.01). During the follow-up period, long-term improvement 
was seen in the VAS I (-20.3 (95% CI -28.9 to -11.6) vs. -4.8 (95% CI -9.8 to 0.2), p<0.05) 
and VAS IV (-7.9 (95% CI -11.96 to -3.9) vs. -0.1 (95% CI -3.7 to 3.6), p<0.05) parameters 
of the 36°C thermal water group and in the VAS III (-19.0 (95% CI -27.5 to -10.5)  
vs. -4.1 (95% CI -10.6 to 2.4), p<0.05) and VAS IV (-15.3 (95% CI -20.0 to -10.7) vs. -0.1 
(95% CI -3.7 to 3.6), p<0.01) scores of the 38°C thermal water group compared with control. 
Remarkable and long-term improvement was noted in the grip and pinch strengths of both 
hands in the thermal water groups at all study time points. By the end of week 3, the grip 
strength of the right hand significantly improved in patients treated with 36°C thermal water 
compared with the control group (3.8 (95% CI 0.8 to 6.8) vs. -0.1 (95% CI -1.5 to 1.3), 
 Allocated to intervention group 1 
 thermal water – 36 oC (n=21) 
 Received allocated intervention (n=19) 
 Did not receive allocated intervention (n=2) 
 (lack of compliance) 
 Lost to follow-up (n=0)  Lost to follow-up (n=0) 
 Analyzed intention to treat (n=21)  Analyzed intention to treat (n=21) 
Patients randomly allocated to treatment (n=63) 
 Allocated to intervention group 2 
 thermal water – 38 oC (n=21) 
 Received allocated intervention (n=21) 
 Allocated to control group (n=21) 
 
 Received allocated intervention (n=19) 
 Did not receive allocated intervention (n=2) 
 (lack of compliance) 
 Lost to follow-up (n=0) 
 Analyzed intention to treat (n=21) 
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p<0.05). No significant difference was seen between the thermal water-treated and control 
groups at other study time points. In patients receiving 38°C thermal water therapy, pinch 
strength of the dominant right hand with the control group (0.7 (95% CI 0.3 to 1.1) vs. 0.1 
(95% CI -0.1 to 0.3), p<0.05). This significant improvement lasted even during the follow-up 
period (0.6 (95% CI 0.2 to 1.1) vs. 0.03 (95% CI -0.3 to 0.4), p<0.05). Improvement of the 
HAQ index was significant only in the 38°C thermal water-treated group both after treatment 
(-0.5 (95% CI -0.7 to -0.3) vs. -0.1 (95% CI -0.2 to 0.04), p<0.01) and during the follow-up 
period (-0.4 (95% CI -0.6 to -0.2) vs. -0.1 (95% CI -0.2 to 0.1), p<0.01) compared with the 
control group. Decrease of morning joint stiffness was detectable in all groups. However, no 
significant differences were found between the treated and control groups at any of the time 
points studied. The number of swollen joints significantly decreased in the thermal water 
groups compared with the control group at both time points studied (-1.9 (95% CI -2.8  
to -1.0), -1.9 (95% CI -2.7 to -1.1) vs. -0.2 (95% CI -0.5 to 0.2), p<0.01); -1.9 (95% CI -2.8  
to -0.95), -2.0 (95% CI -2.8 to -1.2) vs. 0.2 (95% CI -0.3 to 0.8), p<0.01). 
A substantial and significant decrease was seen in the number of tender joints in the 
thermal water groups after treatment (-4.2 (95% CI -6.2 to -2.3), -5.1 (95% CI -6.95 to -3.3) 
vs. -0.4 (95% CI -1.1 to 0.4), p<0.01) and during follow up (-3.95 (95% CI -5.8 to -2.1), -5.3 
(95% CI -7.2 to -3.5) vs. -0.1 (95% CI -0.8 to 0.5), p<0.01) compared with the control group. 
The SF-36 health survey questionnaire documented a substantial and permanent 
improvement of physical component summary (PCS) scores in the thermal water-treated 
groups, right after the therapy and during the follow-up period. After the three-week 
treatment, this improvement was significantly better in the 38°C thermal water-treated group 
compared with control (6.3 (95% CI 3.9 to 8.6) vs. 2.0 (95% CI 0.3 to 3.7), p<0.05). Mental 
component summary (MCS) scores improved only in the thermal water groups. After week 3, 
this improvement was significantly higher in the 36°C thermal water-treated group compared 
with control (4.8 (95% CI 1.3 to 8.4) vs. -0.5 (95% CI -2.6 to 1.5), p<0.05). During follow-up, 
no significant improvements were noted in the PCS and MCS scores of the thermal water-
treated groups compared with control. 
Direct comparison of the effects of the 36°C and 38°C thermal waters revealed no 
significant differences in the treatment responses. The measured values, changes compared to 
the baseline and statistical data are presented in Table 6. 
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DISCUSSION 
The aim of this study was to assess the effect of balneotherapy in patients with 
osteoarthritis of the hands. Our study is the first assessment of the efficacy of balneotherapy in 
this condition. Based on the results presented here, thermal water treatment was more effective 
in several subjective and objective outcome parameters compared with the control 
magnetotherapy group. It can be postulated that the thermal water at 38° is more effective than 
that at 36°C, since the 38°C water treatment significantly improved the pinch strength of the 
right hand and the HAQ parameters, even in the long term, whereas no significant changes 
were noted in the same parameters in the 36°C thermal water-treated group compared with 
control. 
Mud treatment of small joints of the hands in patients with rheumatoid arthritis has 
decreased the pain intensity and the number of swollen and tender joints [126]. A contrast bath 
procedure applied to small hand joints increased body surface blood flow and skin temperature 
[127]. 
Low-frequency pulsed electromagnetic field (PEMF) therapy is frequently used to treat 
the symptoms of osteoarthritis [128]. It also can provide a non-invasive, safe and easy-to-apply 
method to treat pain, inflammation and dysfunctions associated with osteoarthritis [129]. 
The small improvements in the control group confirm the inconclusive effect of 
magnetotherapy (i.e. nine studies performed based on the analysis of the data of 483 patients 
with knee osteoarthritis revealed significant improvement only in quality of life but not in pain 
and joint stiffness); therefore, it is recommended as adjuvant therapy [130]. 
Positive effects of balneotherapy on quality of life were confirmed by a large Italian 
study, the Naiade Project. According to the results of the Naiade study, balneotherapy 
treatment significantly decreased the need for other treatments (hospitalization, physical and 
pharmaceutical therapy) and decreased loss of working hours in patients with osteoarthritis 
[131]. 
The current study had some limitations in addition to its small sample size. It remains 
to be determined whether the present results were due to the effects of balneotherapy alone or 
the combined effects of balneo- and magnetotherapy. Since no specific, validated Hungarian 
hand function tests are available, HAQ was used for the assessment of functional status of the 
hands. 
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Table 6. Measured values, changes compared to the baseline, and statistical data of groups at various time points of the study 
Assessment 2 (3 weeks later)      Assessment 3 (13 weeks later)  Changes compared to the baseline Group comparison Changes compared to the baseline Group comparison 
 Thermal water 36 °C 
Thermal water 
38 °C Control 
Thermal water 
36 °C 
Thermal water 
38 °C Control 
 Mean  95% CI Mean  95% CI Mean  95% CI 
Thermal water 
36 °C – 
Control 
Thermal water 
38 °C – 
Control Mean  
95% CI 
Mean  
95% CI 
Mean  
95% CI 
Thermal water 
36 °C – 
Control 
Thermal water 
38 °C – 
Control 
VAS I -28.9 -38.2 to -19.5 
-21.5 
-29.8 to -13.2 
-11.4 
-19.1 to -3.8 p<0.05 NS 
-20.3 
-28.9 to -11.6 
-17.7 
-26.2 to -9.2 
-4.8 
-9.8 to 0.2 p<0.05 NS 
VAS II -28.2 -36.5 to -19.9 
-23.2 
-31.9 to -14.6 
-9.95 
-20.1 to 0.2 p<0.05 NS 
-20.7 
-30.6 to -10.8 
-23.8 
-33.3 to -14.3 
-9.8 
-19.6 to -0.02 NS NS 
VAS III -18.7 -28.3 to -9.2 
-17.95 
-25.7 to -10.3 
-6.5 
-11.3 to -1.6 NS NS 
-16.6 
-24.5 to -8.8 
-19.0 
-27.5 to -10.5 
-4.1 
-10.6 to 2.4 NS p<0.05 
VAS IV -9.2 -12.5 to -5.9 
-14.6 
-19.9 to -9.2 
-3.0 
-5.9 to -0.1 NS p<0.01 
-7.9 
-11.96 to -3.9 
-15.3 
-20.0 to -10.7 
-0.1 
-3.7 to 3.6 p<0.05 p<0.01 
Grip strength 
right hand (kg) 
3.8 
0.8 to 6.8 
3.5 
1.2 to 5.8 
-0.1 
-1.5 to 1.3 p<0.05 NS 
3.7 
-0.2 to 7.6 
4.0 
1.1 to 6.9 
0.3 
-1.4 to 1.9 NS NS 
Grip strength 
left hand (kg) 
2.99 
0.4 to 5.6 
2.7 
0.8 to 4.7 
0.6 
-1.0 to 2.2 NS NS 
2.7 
-0.3 to 5.6 
4.4 
1.4 to 7.3 
-0.1 
-1.7 to 1.5 NS NS 
Pinch strength 
right hand (kg) 
0.6 
0.2 to 0.9 
0.7 
0.3 to 1.1 
0.1 
-0.1 to 0.3 NS p<0.05 
0.4 
0.1 to 0.7 
0.6 
0.2 to 1.1 
0.03 
-0.3 to 0.4 NS p<0.05 
Pinch strength 
left hand (kg) 
0.3 
0.1 to 0.5 
0.6 
0.3 to 0.9 
0.3 
0.1 to 0.5 NS NS 
0.3 
0.04 to 0.6 
0.4 
0.1 to 0.7 
0.1 
-0.1 to 0.4 NS NS 
HAQ -0.2 -0.4 to -0.1 
-0.5 
-0.7 to -0.3 
-0.1 
-0.2 to 0.04 NS p<0.01 
-0.2 
-0.5 to -0.03 
-0.4 
-0.6 to -0.2 
-0.1 
-0.2 to 0.1 NS p<0.01 
Morning joint 
stiffness (min) 
-5.4 
-7.9 to -2.9 
-8.1 
-13.9 to -2.2 
-1.7 
-4.4 to 1.1 NS NS 
-4.7 
-7.3 to -2.1 
-6.6 
-11.5 to -1.6 
-1.2 
-2.3 to -0.1 NS NS 
Swollen 
joint count 
-1.9 
-2.8 to -1.0 
-1.9 
-2.7 to -1.1 
-0.2 
-0.5 to 0.2 p<0.01 p<0.01 
-1.9 
-2.8 to -0.95 
-2.0 
-2.8 to -1.2 
0.2 
-0.3 to 0.8 p<0.01 p<0.01 
Tender 
joint count 
-4.2 
-6.2 to -2.3 
-5.1 
-6.95 to -3.3 
-0.4 
-1.1 to 0.4 p<0.01 p<0.01 
-3.95 
-5.8 to -2.1 
-5.3 
-7.2 to -3.5 
-0.1 
-0.8 to 0.5 p<0.01 p<0.01 
PCS 5.5 2.7 to 8.2 
6.3 
3.9 to 8.6 
2.0 
0.3 to 3.7 NS p<0.05 
5.1 
1.8 to 8.5 
4.9 
2.2 to 7.7 
1.8 
-0.6 to 4.3 NS NS SF 36 
MCS 4.8 1.3 to 8.4 
4.2 
1.2 to 7.2 
-0.5 
-2.6 to 1.5 p<0.05 NS 
1.7 
-2.3 to 5.7 
3.4 
0.8 to 6.0 
-0.1 
-1.9 to 1.7 NS NS 
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III. EVALUATION OF THE EFFECT OF LAKE HÉVÍZ THERMAL MINERAL 
WATER IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE, A SINGLE-
BLIND, RANDOMIZED, CONTROLLED FOLLOW-UP STUDY 
 
OBJECTIVES 
Studies involving patients with knee osteoarthritis and systematic reviews confirmed 
the analgesic and knee function improving effect of balneotherapy as well as its positive 
influence on quality of life. However, in most of the studies, bath therapy was combined with 
other therapies (exercise program, massage, showers, mud therapy) [86,87,132,133]. 
Furthermore, only a limited number of previous studies covered the assessment of quality of 
life. Therefore, the primary endpoint of the study was the evaluation and documenting of the 
pain-reducing effect of Lake Hévíz thermal mineral water on knee pain at rest or on exertion 
in patients with mild to moderate knee osteoarthritis as well as the assessment of the 
therapeutic effect compared to the control group treated with warmed tap water. The 
secondary endpoints included the evaluation of the effect of Lake Hévíz thermal mineral 
water on knee function and quality of life. 
 
MATERIALS AND METHODS 
Design 
This was a randomized, single-blind, controlled, parallel-group, follow-up study. The 
study was conducted in accordance with the Declaration of Helsinki, International Conference 
on Harmonization / Good Clinical Practice standards and was approved by the Regional 
Research Ethics Committee (Approval No. 18/2011). 
 
Participants 
This study included male and female patients between 45 and 75 years of age with 
mild to moderate, bilateral primary osteoarthritis of the knee (meeting the American College 
of Rheumatology knee osteoarthritis classification criteria [134]) diagnosed and documented 
with imaging techniques (comparative knee radiograph not older than 2 years). Patients had 
been suffering from knee pain characteristic for osteoarthritis for at least 3 months. 
Exclusion criteria were conditions and diseases excluding warm water bath treatment 
(patients suffering from any severe internal, rheumatic, urogenital, or skin disorders or mental 
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illnesses, which contraindicates bath treatment). Intraarticular corticosteroid injection within 1 
month prior to the start of treatment, intraarticular hyaluronic acid therapy within 6 months 
prior to the initiation of treatment. Physiotherapy within 3 months prior to the start of 
treatment. Any change in nonsteroidal anti-inflammatory therapy or chondroprotective 
therapy within 1 month prior to treatment. Patients suffering from inflammatory rheumatic 
diseases (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, crystal arthropathies, 
etc.), patients with palpable fluid in the knee. Knee surgery within 6 months prior to the 
study; presence of metal implant in the knee joint. Patients with any previous fractures in the 
knee area, and/or knee injury within 6 months prior to the study. Patients with hip or spinal 
surgery within a year preceding the study. Patients with radiculopathy. 
 
Study procedures 
The study took place at Spa Hévíz and St. Andrew Hospital for Rheumatic Diseases 
(H-8380 Hévíz, Dr. Schulhof Vilmos sétány 1, Hungary), from May 2012 to August 2012. 
After verbal agreement, the physician of the Rheumatology Outpatient Clinic of Keszthely 
City Hospital and the rheumatologists of our Institute invited the patients to join the study, 
bearing in mind the inclusion and exclusion criteria. The enrolled patients received the 
treatment in an outpatient setting and they were able to continue their daily activities and 
work. The specialists of our Institute and the members of the Lake Hévíz Emergency 
Medicine Team were constantly available during the treatment for the management of side 
effects and problems emerging during treatment. Before enrollment, study participants were 
informed verbally and in writing about the purpose of the study and the study procedures. 
Prior to enrollment, patients read the Patient Information Sheet and signed the Informed 
Consent Form. 
Patients were randomized into one of the two treatment groups. One group was treated 
in a covered area of Lake Hévíz and the control group was treated in a (1.2 to 1.4 m deep) 
pool bath filled with tap water of the same temperature as that of the thermal water. During 
the study, the temperature of the lake bath (34°C) was the same as that of the pool bath. 
Patients received Lake Hévíz or pool bath treatment for 30 minutes 5 days a week, a total of 
15 times. Patients were asked not to swim during bathing. 
In order to follow up the patients, they were constantly under supervision during the 
treatment. Patients were considered as having completed the study if they participated in more 
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than 80% of the treatment sessions. Patients did not receive any other physiotherapy in 
addition to the bath therapy. Further balneo/physiotherapy treatment, intraarticular 
corticosteroid or hyaluronic acid therapy, arthroscopic surgery, any change in nonsteroidal 
anti-inflammatory therapy or chondroprotective therapy was not allowed during the study and 
follow-up. Participants were evaluated just before treatment (Week 0), after the end of 
treatment (Week 3), and during the follow-up visit (Week 15). Patients were examined by 
seven rheumatologists. Before the study, the study personnel standardized and practiced joint 
assessment two times on patients not participating in the study. Patients randomized into the 
control group were given the opportunity to bath in the lake for free 15 times after the follow-
up visit. 
 
Randomization and blinding 
Patients were randomly assigned into two groups following simple randomization with 
a computer-generated sequence. The randomizer was not involved in the conduction of the 
study. The randomizer received the information about the patients in e-mail. The person 
performing the statistical analysis did not participate in the randomization process. After 
randomization an independent person assigned the participants to the appropriate groups. 
Baseline and post-therapy assessments were performed by rheumatologists. The same patient 
was examined by the same physician every time. The examiners were blinded regarding the 
received therapy. Patients were told not to inform the study doctor about whether they 
received balneotherapy in Lake Hévíz or in the pool. 
 
Evaluations 
Characteristics of knee pain and condition were assessed on a 0-100 mm scale as 
follows: VAS I: knee pain at rest, as rated by the patient. VAS II: knee pain on exertion, as 
rated by the patient. VAS III: condition of the knee, as rated by the patient. VAS IV: 
condition of the knee, as rated by the investigator. WOMAC index was used to characterize 
knee joint pain, joint stiffness, and physical function. Angle of knee flexion on the left and 
right side measured by a goniometer (angle). Knee circumference (cm). Stair-climb time in 
seconds to walk up 22 stairs in the pool bath building of the Hospital. EQ-5D a self-report 
questionnaire for the measurement of general health-related quality of life. 
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Thermal water composition 
The thermal mineral water of Lake Hévíz is rich in dissolved and gas components, 
thereby it combines the favorable characteristics of carbonate, sulfur, calcium, magnesium, 
hydrogen carbonate and very light radon-containing waters. The characteristics and mineral 
composition of Lake Hévíz water are shown in Table 7.  
 
Table 7. Characteristics and mineral composition of Lake Hévíz water 
Total hardness of water 198 CaO mg/l 
pH 7.14 
Water temperature in summer: 32-35 °C, in winter 24-26 °C 
 covered lake bath in which the study was conducted: 32 to 34°C 
Cations mg/l Anions mg/l 
Sodium 21.7 Chlorine 25 
Potassium 6.45 Bromine 0.11 
Ammonium 0.22 Iodine 0.021 
Calcium 82.1 Fluorine 1.18 
Magnesium 36 Sulphate 63 
Iron 0.24 Hydrogen carbonate 384 
Lithium 0.07 Sulphide 3.2 
Sum. 151  470 
Others mud, radon, meta borid acid, meta silica acid, organic acid, special ecosystem, CO2, soluble O2 
 
Statistical analysis 
Sample size calculation was based on power analysis (α=0.05, β=0.80, effect 
size=0.65). Results were processed and evaluated in Microsoft Excel. For the statistical 
comparison of the samples, self-controlled and group-controlled methods: one-sample 
(paired) and two-sample t-tests were used. The analysis of the results was conducted by 
intention to treat. In order to avoid overestimation of the therapeutic effect, data from 
dropped-out patients were replaced by data of the last measurement. The level of significance 
was set at p < 0.05. 
 
RESULTS 
Of the 77 patients included in the study, 75 completed more than 80% of the therapy 
sessions. Demographic and baseline clinical characteristics of patients are shown in Table 8. 
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Table 8. Demographic data and other baseline clinical characteristics of the patients by treatment group 
 Thermal water Control 
Enrolled, male, female n = 38, 8/30 n = 39, 9/30 
 Mean (SD) Mean (SD) 
Age 65.6 (6.4) 65.5 (7.7) 
VAS I at rest 33.6 (23.4) 33.2 (21.8) 
VAS II on exertion 55.2 (20.2) 58.0 (20.9) 
VAS III patient's assessment 52.1 (20.1) 53.5 (16.0) 
VAS IV physician's assessment 46.2 (15.0) 51.2 (16.1) 
Pain 38.5 (23.5) 46.6 (19.9) 
Stiffness 49.4 (26.9) 51.2 (20.6) 
W
OM
AC
 
Function 43.4 (21.7) 44.5 (17.8) 
Flexion, right side 109.1 (15.5) 111.3 (18.5) 
Flexion, left side 112.6 (12.5) 113.3 (17.4) 
Circumference, right side 40.4 (3.7) 40.9 (4.3) Kn
ee
 
Circumference, left side 40.3 (3.8) 40.7 (4.5) 
Stair-climb time 20.3 (3.6) 21.9 (5.1) 
EQ-5D 0.6281 (0.2406) 0.6005 (0.2035) 
EQ-5D VAS 59.1 (16.6) 54.7 (15.9) 
 
Treatment groups were similar with regard to demographic data and baseline clinical 
characteristics. Two patients discontinued the treatment (1 patient in the thermal group and 1 
patient in the control group). Two patients in the control group did not attend the Visit 3. 
Disposition of patients is presented in Figure 3. 
 
Figure 3. Disposition of the patients 
 
 Allocated to intervention group (n=38) 
 Received allocated intervention (n=37) 
 Did not receive allocated intervention (n=1) 
 (1 – knee joint inflammation) 
 Allocated to control group (n=39) 
 Received allocated intervention (n=38) 
 Did not receive allocated intervention (n=1) 
 (1 - Erysipelas) 
Lost to follow-up (n=0) (lack of compliance) Lost to follow-up (n=2) (lack of compliance) 
 Analyzed intention to treat (n=39)  Analyzed intention to treat (n=38) 
 Excluded (n=23) 
 Not meeting inclusion criteria  (n=23) 
 Decline to participate (n=0) 
Assessed for eligibility (n=100) 
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Examination of the knee revealed an improvement in the pain parameters measured by 
VAS scale in both study groups. After the 3-week treatment, patients receiving thermal water 
therapy showed a significant therapeutic response compared to the control group, with a 
decrease in VAS I (-21.1 (95% CI -27.7 to -14.6) vs. -3.7 (95% CI -9.6 to -2.2) p<0.01), 
VAS II (-22.8 (95% CI -27.1 to -18.5) vs. -6.8 (95% CI -12.0 to -1.7) p<0.01), VAS III  
(-21.7 (95% CI -27.1 to -16.3) vs. -8.5 (95% CI -13.1 to -3.9) p<0.01), and VAS IV  
(-15.1 (95% CI -18.6 to -11.5) vs. -8.0 (95% CI -11.7 to -4.3) p<0.01) scores. During the 
follow-up period, long-term improvement was seen in all of the VAS scales: VAS I -18.8 
(95% CI -26.0 to -11.5) vs. -2.8 (95% CI -10.5 to 5.0) (p<0.01), VAS II -19.0 (95% CI -25.6 
to -12.4) vs. -2.4 (95% CI -8.8 to 4.0) (p<0.01), VAS III -19.9 (95% CI -27.1 to -12.8) vs. -6.2 
(95% CI -11.0 to -1.3) (p<0.01), and VAS IV -16.5 (95% CI -21.3 to -11.7) vs. -5.6 (95% CI 
-9.8 to -1.3) (p<0.01). 
In the thermal water-treated group, all three dimensions of the WOMAC index (pain, 
joint stiffness, function) showed significant improvement after the treatment and during the 
follow-up period. Comparing the changes in the study groups, all three parameters of the 
WOMAC index showed significantly better improvement in the thermal water-treated group 
than in the control group: pain subscales -11.9 (95% CI -16.7 to -7.1) vs. -5.5 (95% CI -9.5 
to -1.6) (p<0.05), stiffness subscales -18.2 (95% CI -24.7 to -11.7) vs. -3.6 (95% CI -7.8 
to 0.7) (p<0.01), function subscales -15.5 (95% CI -20.0 to -11.0) vs. -2.7 (95% CI -5.7 
to 0.3) (p<0.01), and function score during follow-up -12.0 (95% CI -18.6 to -5.4) vs. -3.9 
(95% CI -7.9 to 0.1) (p<0.05). 
Knee function and movement were characterized by changes in flexion angles. In 
response to treatment, knee flexion improved in both knee in both groups. Improvement of 
joint function was significantly better in the thermal water-treated group than in the control 
group: flexion changes were 15.4 (95% CI 11.7 to 19.1) vs. 6.1 (95% CI 1.8 to 10.5) (p<0.01) 
in the right knee and 11.9 (95% CI 4.7 to 19.2) vs. 3.3 (95% CI 0.7 to 6.0) (p<0.05) in the left 
knee. Similar results were obtained during the follow-up period: right knee flexion was 14.9 
(95% CI 11.9 to 17.9) vs. 5.9 (95% CI 2.4 to 9.5) (p<0.01) and left knee flexion was 14.7 
(95% CI 11.4 to 18.1) vs. 2.8 (95% CI -0.9 to 6.6) (p<0.01). 
As a response to treatment, stair-climb time decreased in both groups; patients 
completed the unit distance in a shorter period of time. Stair-climb time was slightly more 
  
51 
decreased in the thermal water-treated group than in the control group when compared to 
baseline. The difference between the two groups was not significant. 
The utility index of the EQ-5D questionnaire showed permanent and significant 
improvement of general health-related quality of life in the thermal water-treated group 
compared to the control group after the treatment 0.1606 (95% CI 0.0975 to 0.2237) vs. 
0.0634 (95% CI 0.0000 to 0.1268) (p<0.05) and during the follow-up period 0.1062 (95% CI 
0.0328 to 0.1797) vs. -0.0263 (95% CI -0.1073 to 0.0547) (p<0.05). The responders' self-rated 
health measured on the EQ-5D VAS scale slightly improved, but the changes were not 
statistically significant between the two groups. 
 
DISCUSSION 
In this randomized, controlled, single-blind, follow-up study we evaluated the 
effectiveness of thermal mineral water on pain, function and quality of life in patients with 
knee osteoarthritis. The primary endpoint parameters indicating pain at rest and on exertion 
measured on a visual analogue scale and the secondary endpoint parameters such as the 
physical function parameter of the WOMAC index, angle of knee flexion, and index values of 
the EQ-5D global health-associated quality of life questionnaire showed greater improvement 
and were statistically significant and more durative in the thermal water-treated group 
compared to the control group. The difference in the above mentioned parameters were 
significant between the two groups at the end of treatment and during the follow-up period. 
No adverse reactions were observed during treatment sessions or during the whole study 
period. The results of our study demonstrated explicitly the effects of thermal mineral water, 
in the short and long term, compared to the control group who were treated with the tap water. 
The decrease in pain was not only statistically but also clinically significant. In our own study 
the VAS scales for the reduction in pain showed a more informative response. The vast 
majority of studies compared the thermal mineral water treatment for outpatient care with a 
group not receiving such treatment [132,135,136]. 
Many Hungarian, Turkish, Israeli authors study compares the treatment of thermal 
mineral water with tap water treatment. Studies were carried out on treatment with waters of 
different mineral content. Similar to our results in previous studies comparing the efficacy of 
balneotherapy applied as a 15 to 18 day course to tap water control in patients with knee 
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osteoarthritis [83,113] a significant decrease in pain was observed. Some patients in the group 
treated with tap water also showed improvements, which confirms the well-known analgesic 
effect of hot water, but the effect of short-term thermal mineral water proved to be 
significantly better [137]. This has ratified a systematic review and meta-analysis published 
by Bender and associates in 2013 which analyzed the pain-reducing effect of balneotherapy. 
Based on their results, regardless of the composition of the mineral water, balneotherapy 
significantly decreased joint pain in patients with chronic low back pain and knee and hand 
osteoarthritis [88]. 
After the treatment, the WOMAC index parameters of pain, stiffness, physical 
function and even longterm physical function showed significant clinical improvements. 
Reduction in pain and improvement in WOMAC scores were most prominent after the 
treatment course; and at Week 15 this effect already showed a decreasing trend. These results 
differ from the results of Fioravanti and associates published in 2012, who compared the 
effects of balneotherapy with routine regular outpatient care and found further reduction in 
pain, parameters of WOMAC and Lequesne indexes at the 3-month follow-up visit [135]. 
In contrast, if the thermal mineral water treatment was applied intermittently twice a 
week for 6 weeks, no significant difference was observed between the treatment group and the 
tap water-treated control group in pain decrease, improvement in the Lequesne and WOMAC 
indexes, and improvement in the parameters of the SF-36 questionnaire [136]. 
Few previous studies have focused on the assessment of changes in the physical state. 
Our results of knee flexion, showed significant improvement after treatment compared to the 
control group and during follow-up as well. The stair climb speed improved in both groups, 
although the change in the thermal mineral water treated group was greater, but no significant 
difference was observed when comparing the groups. In contrast to our results in a study by 
Kovacs and Bender it was showed that the stair-climb time improved significantly following 
3 week balneotherapy [113]. 
Only a limited number of studies evaluated the effect of balneotherapy on quality of 
life. In our study, EQ-5D a self-report questionnaire was evaluated, after the treatment and 
during the 3-month follow-up period, significant improvement was noted. In other studies, 
using the SF-36 questionnaire and the Arthritis Impact Measurement Scales a significant 
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improvement in quality of life was seen at the end of the treatment course and during the 3-
month follow-up period [135,136,137]. 
In studies where balneotherapy was combined with exercise and other treatments 
[132,138], even in case of severe knee osteoarthritis [139], pain decrease as well as 
improvement in muscle strength, walking distance, physical function, and quality of life was 
found to be more significant and longer term. These results were supported by a multicentre 
study involving a large number of patients [84]. 
With regard to the common side effects of continuous pharmacological, NSAID 
therapy, a balneotherapy course can be a useful therapeutic tool or adjunctive therapy in the 
treatment of knee osteoarthritis. 
Our study has some limitations. First, those patients, who bathed in the covered part of 
the lake, were not allowed to swim, due to the deepness of the water, they had a better 
opportunity to move around. This might have influenced the improvement in function. Further 
studies should include larger sample, maybe as a multicenter study. A larger number of 
patients would have increased the power of the study. Furthermore, patients were not blinded 
to the received therapy. Bathing in the lake did not make the application of the double-blind 
method possible. In the future the double-blind method should be used with the tap water 
control group to ratify the effectiveness of the thermal water treatment. On the other hand 
patients randomized into the control group were given the opportunity to bathe in the lake for 
free 15 times after the follow-up visit. This could have led to the results being influenced, 
however, this contradicts the documented improvement of the control group also. Finally, in a 
future study it would be useful to design longer follow-up periods and to associate it with a 
study into its cost-effectiveness. 
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Table 9. Measured values, changes from baseline, and statistical data of groups at various time points of the study  
  Assessment 2 (3 weeks later) Assessment 3 (15 weeks later) 
  Changes from baseline Group comparison Changes from baseline 
Group 
comparison 
  Thermal water Control Thermal water Control 
  Mean 95% CI Mean 95% CI 
Thermal water 
– 
Control 
Mean 
95% CI Mean 95% CI 
Thermal water 
– 
Control 
VAS I -21.1 -27.7 to -14.6 
-3.7 
-9.6 to 2.2 p<0.01 
-18.8 
-26.0 to -11.5 
-2.8 
-10.5 to 5.0 p<0.01 
VAS II -22.8 -27.1 to -18.5 
-6.8 
-12.0 to -1.7 p<0.01 -19.0 -25.6 to -12.4 
-2.4 
-8.8 to 4.0 p<0.01 
VAS III -21.7 -27.1 to -16.3 
-8.5 
-13.1 to -3.9 p<0.01 
-19.9 
-27.1 to -12.8 
-6.2 
-11.0 to -1.3 p<0.01 
VAS IV -15.1 -18.6 to -11.5 
-8.0 
-11.7 to -4.3 p<0.01 
-16.5 
-21.3 to -11.7 
-5.6 
-9.8 to -1.3 p<0.01 
Pain -11.9 -16.7 to -7.1 
-5.5 
-9.5 to -1.6 p<0.05 
-9.2 
-15.2 to -3.2 
-6.8 
-10.4 to -3.1 NS 
Stiffness -18.2 -24.7 to -11.7 
-3.6 
-7.8 to 0.7 p<0.01 
-14.0 
-21.9 to -6.2 
-7.1 
-12.4 to -1.8 NS 
W
OM
AC
 
Function -15.5 -20.0 to -11.0 
-2.7 
-5.7 to 0.3 p<0.01 
-12.0 
-18.6 to -5.4 
-3.9 
-7.9 to 0.1 p<0.05 
Flexion 
right side 
15.4 
11.7 to 19.1 
6.1 
1.8 to 10.5 p<0.01 
14.9 
11.9 to 17.9 
5.9 
2.4 to 9.5 p<0.01 
Flexion 
left side 
11.9 
4.7 to 19.2 
3.3 
0.7 to 6.0 p<0.05 
14.7 
11.4 to 18.1 
2.8 
-0.9 to 6.6 p<0.01 
Circumference 
right side 
-0.3 
-0.7 to 0.1 
-0.1 
-0.3 to 0.1 NS 
-0.4 
-0.8 to 0.0 
-0.2 
-0.7 to 0.4 NS 
Kn
ee
 
Circumference 
left side 
-0.4 
-0.8 to -0.1 
-0.1 
-0.4 to 0.2 NS 
-0.6 
-1.1 to -0.1 
0.2 
-0.4 to 0.7 NS 
Stair-climb time -3.2 -4.3 to -2.2 
-1.6 
-3.0 to -0.3 NS 
-1.5 
-3.1 to 0.1 
-1.4 
-2.3 to -0.4 NS 
EQ-5D 0.1606 0.0975 to 0.2237 
0.0634 
0.0 to 0.1268 p<0.05 
0.1062 
0.0328 to 0.1797 
-0.0263 
-0.1073 to 0.0547 p<0.05 
EQ-5D VAS 6.1 -1.5 to 13.6 
2.5 
-2.5 to 7.4 NS 
5.1 
-2.1 to 12.3 
-4.4 
-10.7 to 2.0 NS 
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SUMMARY 
Balneotherapy a medical specialty using the beneficial effects of naturally found mineral waters, 
gases, and peloids. The most important modalities of use are bathing, drinking and inhalation. The 
mechanism of action of balneotherapy is not yet completely understood. The physical properties and 
chemical effects of thermal mineral waters may play a role in their mechanism of action, and the 
physical effects of buoyancy, hydrostatic pressure and water temperature may be highlighted. 
Balneotherapeutic procedures are mainly performed in the prevention, treatment, and rehabilitation 
of musculoskeletal diseases but their use have also been reported in various other indications such as 
in the treatment or rehabilitation of dermatological, gynaecological, chronic venous insufficiency, 
chronic occlusive arterial disease, or psychiatric conditions as well as in the rehabilitation of 
oncology patients. Balneotherapy is usually part of a complex physiotherapeutic treatment. The 
effectiveness of balneotherapy was long known only empirically. In the past decades, several 
clinical studies, reviews, and meta-analyses have evaluated the efficacy of balneotherapy mainly in 
the treatment of musculoskeletal disorders. Balneology is often not recognised as independent 
medical specialty at a global international and domestic level, because of the lack of scientific 
evidence, and the fact that balneotherapy is not available in all countries. Low back pain and 
osteoarthritis are prevalent diseases and their impact is pervasive. The prevalence of these 
conditions increases markedly with age and they are affected by lifestyle factors, such as obesity and 
lack of physical activity. They are common cause of severe and chronic pain and physical disability, 
and they influence the quality of life of affected people. The need for high-quality care for a 
condition with major personal and societal impact is generally recognised and several guidelines for 
such care are available. International recommendations for management of musculoskeletal diseases 
are often divided into three main categories: non-pharmacological, pharmacological and surgical. 
The efficacy of balneotherapy has been most clearly evidenced in gonarthrosis. Based on systematic 
review and metaanalysis of randomized controlled trials, recommendations mention balneotherapy 
as a therapeutic option for knee osteoarthritis. In the recently published Osteoarthritis Research 
Society International Guidelines for Non-Surgical Management of Knee Osteoarthritis, 
balneotherapy was considered as an appropriate treatment for specific clinical subphenotypes with 
multiple joint osteoarthritis and comorbidities. Balneotherapeutic procedures are widely used by 
physicians and preferred by patients for the treatment of chronic low back pain. Because of the 
limited scientific evidence balneotherapy is not included in the treatment guidelines for low back 
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pain. The first meta-analysis available in English evaluated pooled data from only 5 studies. The 
first single-blind study was published concomitantly with the above meta-analysis. Evaluating the 
effectiveness of balneotherapy presents specific methodological issues. In non-pharmacological 
treatments trials, it is often difficult to perform sham intervention, and blinding of participants is 
frequently impossible. Moreover, the success of balneotherapy often depends on environmental and 
other specific factors such as chemical and thermal characteristics, type of bath, nature, and 
combined intervention. The metaanalysis of completed trials in balneology is challenged by the 
diversity of their methods, therapies, and outcome parameters. Unlike for drug trials, the lack of 
adequate funding of balneology research makes it difficult to enroll sufficient numbers of patients in 
such trials. Metaanalyses and review studies on the efficacy of balneotherapy evaluated the analyzed 
randomized, controlled trials as of inappropriate methodology. The authors emphasize the need for 
further additional, confirmatory studies which include an analysis of the person’s physical function 
and their quality of life. Therefore, we aimed to design our studies with appropriate methodology, in 
accordance with the recommendations for study planning. These trials may provide data for a more 
precise evaluation of the role of balneotherapy in the management of each condition.  
I. The aim of the current study was to evaluate the effectiveness of thermal mineral water 
compared with tap water in the treatment of patients with low back pain, with pain level, mobility 
and quality of life as primary end-points. Secondary end-points were to record changes in the dose 
requirements of analgesics and explore the safety profile of treatment. This randomized, double-
blind, controlled, follow-up study included 71 patients who underwent 20-minute daily treatment 
sessions with medicinal water or with tap water, both at a temperature of 34°C, on 21 occasions. 
Both groups underwent additional adjunctive electrotherapy. Outcome measures were visual 
analogue scale scores, Schober’s sign, Domján’s signs, Oswestry Disability Index and SF-36 
questionnaire. The study parameters were administered at baseline, immediately after treatment, 
and after 15 weeks. After treatment, there was a significant improvement in all parameters in the 
thermal water group. This improvement was still evident after 15 weeks. The improvement in the 
control group was less substantial compared with baseline values. Comparison of the 2 treatments 
revealed a statistically significant difference in 3 outcome parameters (visual analogue scale 
scores III, IV and Schober’s index). In the subset of patients who completed the study according 
to the protocol, the greater efficacy of treatment with thermal water was also confirmed by the 
other study parameters. No adverse reactions were observed during treatment sessions or during 
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the whole study period. Potential changes in the efficacy of analgesic therapy could not be 
monitored, due to the small number of subjects who took analgesics regularly.  
II. Our primary objective was to evaluate how thermal mineral water therapy influences pain, 
hand function and quality of life in patients with hand osteoarthritis compared with the control 
group. The secondary objective of the study was to evaluate whether different water temperatures 
influence clinical parameters. In this controlled single-blind follow-up study, patients between 50 
and 70 years of age with hand osteoarthritis, randomly assigned into three groups. The subjects in 
the first two groups bathed in thermal mineral water of two different temperatures (36°C and 
38°C) for three weeks five times a week for 20 minutes a day and received magnetotherapy to 
their hands three times weekly. The third group received only magnetotherapy. Outcome 
measures were visual analogue scale scores, handgrip strength, pinchgrip strength, the number of 
swollen and tender joints of the hand, the duration of morning joint stiffness, HAQ, and SF-36 
questionnaire. The study parameters were administered at baseline, immediately after treatment 
and after 13 weeks. The study included 63 patients. Statistically significant improvement was 
observed in several studied parameters after the treatment and during the follow-up study in the 
thermal water groups versus the control group. The 38°C thermal water treatment significantly 
improved the pinch strength of the right hand and the HAQ parameters even in the long term.  
III. The primary endpoint of the study was the evaluation and documenting of the pain-reducing effect of 
Lake Hévíz thermal mineral water on knee pain at rest or on exertion in patients with mild to moderate 
knee osteoarthritis as well as the assessment of the therapeutic effect compared to the control group 
treated with warmed tap water. The secondary endpoints included the evaluation of the effect of Lake 
Hévíz thermal mineral water on knee function and quality of life. In this single-blind, follow-up study 
included 77 outpatients between 45 and 75 years of age with mild to moderate osteoarthritis of the knee 
meeting the American College of Rheumatology classification criteria. Patients were randomized into 
two groups. In group I, subjects bathed in Lake Hévíz and in group II, patients were treated in a pool full 
of tap water. Water temperature was 34°C for both groups. Participants underwent 30-minute therapy 
sessions, five times a week for three weeks. Outcome measures were pain visual analogue scale scores, 
active flexion degree, knee circumference, stair-climb time, WOMAC and EQ-5D. Study parameters 
were recorded at baseline, immediately after treatment, and after 15 weeks. Comparison of the two 
groups revealed a statistically significant difference in pain visual analogue scale scores, active flexion 
degree, physical function components of WOMAC, and EQ-5D scores even after 15 weeks.
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CONCLUSIONS AND NEW RESULTS 
I. Our randomized, tap water-controlled, follow-up study is the first double-blind 
investigation in the English literature evaluating the efficacy of balneotherapy in patients with 
chronic low back pain. Our results suggest that treatment with thermal mineral waters is an 
effective treatment modality for the management of chronic lumbar pain, besides improves 
the function and quality of life. In view of the differences between the groups treated with 
thermal versus tap water, balneotherapy with the former may be regarded as a more effective 
basic treatment modality, as well as an efficient adjunct to pharmaco- and physical therapy, 
owing to the addition and enhancement of positive effects.  
 
II. Our randomized, controlled, single-blind, follow-up study is the first trial in the 
English literature evaluating the effect of balneotherapy in hand osteoarthritis. Based on the 
results thermal water treatment was more effective, clinically significant improvement was 
recorded in pain reduction and hand function, and and quality of life compared with the 
control magnetotherapy group. These benefits were maintained at 13 weeks. The 38°C 
thermal water treatment significantly improved the function compared with control, even in 
the long term. Based on our results, we can conclude that the balneotherapy is a possible 
therapeutic option in the treatment of hand osteoarthritis. 
 
III. Our randomized, tap water-controlled, single-blind study confirmed the findings of 
previous studies on the efficacy of balneotherapy in the treatment of patients with knee 
osteoarthritis. Our results showed significant improvement in knee pain reduction, knee 
function, and quality of life and these changes were measurable even 12 weeks after the 
treatment. The difference, were significant between the two groups at the end of treatment and 
during the follow-up period. With regard to the common side effects of continuous 
pharmacological, NSAID therapy, balneotherapy can be a useful therapeutic tool or 
adjunctive therapy in the treatment of knee osteoarthritis. 
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